{
    "atc": [
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01F",
            "level3_description": "MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES",
            "level4": "L01FD",
            "level4_description": "HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors",
            "level5": "L01FD05",
            "who_name": "trastuzumab duocarmazine"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01F",
            "level3_description": "MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES",
            "level4": "L01FE",
            "level4_description": "EGFR (Epidermal Growth Factor Receptor) inhibitors",
            "level5": "L01FE01",
            "who_name": "cetuximab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01F",
            "level3_description": "MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES",
            "level4": "L01FE",
            "level4_description": "EGFR (Epidermal Growth Factor Receptor) inhibitors",
            "level5": "L01FE02",
            "who_name": "panitumumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01F",
            "level3_description": "MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES",
            "level4": "L01FE",
            "level4_description": "EGFR (Epidermal Growth Factor Receptor) inhibitors",
            "level5": "L01FE03",
            "who_name": "necitumumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01F",
            "level3_description": "MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES",
            "level4": "L01FF",
            "level4_description": "PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors",
            "level5": "L01FF01",
            "who_name": "nivolumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01F",
            "level3_description": "MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES",
            "level4": "L01FF",
            "level4_description": "PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors",
            "level5": "L01FF02",
            "who_name": "pembrolizumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01F",
            "level3_description": "MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES",
            "level4": "L01FF",
            "level4_description": "PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors",
            "level5": "L01FF03",
            "who_name": "durvalumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01F",
            "level3_description": "MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES",
            "level4": "L01FF",
            "level4_description": "PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors",
            "level5": "L01FF04",
            "who_name": "avelumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01F",
            "level3_description": "MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES",
            "level4": "L01FF",
            "level4_description": "PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors",
            "level5": "L01FF05",
            "who_name": "atezolizumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01F",
            "level3_description": "MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES",
            "level4": "L01FF",
            "level4_description": "PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors",
            "level5": "L01FF06",
            "who_name": "cemiplimab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01F",
            "level3_description": "MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES",
            "level4": "L01FF",
            "level4_description": "PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors",
            "level5": "L01FF07",
            "who_name": "dostarlimab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01F",
            "level3_description": "MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES",
            "level4": "L01FF",
            "level4_description": "PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors",
            "level5": "L01FF08",
            "who_name": "prolgolimab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01F",
            "level3_description": "MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES",
            "level4": "L01FF",
            "level4_description": "PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors",
            "level5": "L01FF09",
            "who_name": "tislelizumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01F",
            "level3_description": "MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES",
            "level4": "L01FF",
            "level4_description": "PD-1/PDL-1 (Programmed cell death protein 1/death ligand 1) inhibitors",
            "level5": "L01FF10",
            "who_name": "retifanlimab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01F",
            "level3_description": "MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES",
            "level4": "L01FG",
            "level4_description": "VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors",
            "level5": "L01FG01",
            "who_name": "bevacizumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01F",
            "level3_description": "MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES",
            "level4": "L01FG",
            "level4_description": "VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors",
            "level5": "L01FG02",
            "who_name": "ramucirumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01F",
            "level3_description": "MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES",
            "level4": "L01FX",
            "level4_description": "Other monoclonal antibodies and antibody drug conjugates",
            "level5": "L01FX01",
            "who_name": "edrecolomab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01F",
            "level3_description": "MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES",
            "level4": "L01FX",
            "level4_description": "Other monoclonal antibodies and antibody drug conjugates",
            "level5": "L01FX02",
            "who_name": "gemtuzumab ozogamicin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01F",
            "level3_description": "MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES",
            "level4": "L01FX",
            "level4_description": "Other monoclonal antibodies and antibody drug conjugates",
            "level5": "L01FX03",
            "who_name": "catumaxomab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01F",
            "level3_description": "MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES",
            "level4": "L01FX",
            "level4_description": "Other monoclonal antibodies and antibody drug conjugates",
            "level5": "L01FX04",
            "who_name": "ipilimumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01F",
            "level3_description": "MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES",
            "level4": "L01FX",
            "level4_description": "Other monoclonal antibodies and antibody drug conjugates",
            "level5": "L01FX05",
            "who_name": "brentuximab vedotin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01F",
            "level3_description": "MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES",
            "level4": "L01FX",
            "level4_description": "Other monoclonal antibodies and antibody drug conjugates",
            "level5": "L01FX06",
            "who_name": "dinutuximab beta"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01F",
            "level3_description": "MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES",
            "level4": "L01FX",
            "level4_description": "Other monoclonal antibodies and antibody drug conjugates",
            "level5": "L01FX07",
            "who_name": "blinatumomab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01F",
            "level3_description": "MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES",
            "level4": "L01FX",
            "level4_description": "Other monoclonal antibodies and antibody drug conjugates",
            "level5": "L01FX08",
            "who_name": "elotuzumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01F",
            "level3_description": "MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES",
            "level4": "L01FX",
            "level4_description": "Other monoclonal antibodies and antibody drug conjugates",
            "level5": "L01FX09",
            "who_name": "mogamulizumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01F",
            "level3_description": "MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES",
            "level4": "L01FX",
            "level4_description": "Other monoclonal antibodies and antibody drug conjugates",
            "level5": "L01FX10",
            "who_name": "olaratumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01F",
            "level3_description": "MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES",
            "level4": "L01FX",
            "level4_description": "Other monoclonal antibodies and antibody drug conjugates",
            "level5": "L01FX11",
            "who_name": "bermekimab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01F",
            "level3_description": "MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES",
            "level4": "L01FX",
            "level4_description": "Other monoclonal antibodies and antibody drug conjugates",
            "level5": "L01FX12",
            "who_name": "tafasitamab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01F",
            "level3_description": "MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES",
            "level4": "L01FX",
            "level4_description": "Other monoclonal antibodies and antibody drug conjugates",
            "level5": "L01FX13",
            "who_name": "enfortumab vedotin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01F",
            "level3_description": "MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES",
            "level4": "L01FX",
            "level4_description": "Other monoclonal antibodies and antibody drug conjugates",
            "level5": "L01FX14",
            "who_name": "polatuzumab vedotin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01F",
            "level3_description": "MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES",
            "level4": "L01FX",
            "level4_description": "Other monoclonal antibodies and antibody drug conjugates",
            "level5": "L01FX15",
            "who_name": "belantamab mafodotin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01F",
            "level3_description": "MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES",
            "level4": "L01FX",
            "level4_description": "Other monoclonal antibodies and antibody drug conjugates",
            "level5": "L01FX16",
            "who_name": "oportuzumab monatox"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01F",
            "level3_description": "MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES",
            "level4": "L01FX",
            "level4_description": "Other monoclonal antibodies and antibody drug conjugates",
            "level5": "L01FX17",
            "who_name": "sacituzumab govitecan"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01F",
            "level3_description": "MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES",
            "level4": "L01FX",
            "level4_description": "Other monoclonal antibodies and antibody drug conjugates",
            "level5": "L01FX18",
            "who_name": "amivantamab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XA",
            "level4_description": "Platinum compounds",
            "level5": "L01XA01",
            "who_name": "cisplatin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XA",
            "level4_description": "Platinum compounds",
            "level5": "L01XA02",
            "who_name": "carboplatin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XA",
            "level4_description": "Platinum compounds",
            "level5": "L01XA03",
            "who_name": "oxaliplatin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XA",
            "level4_description": "Platinum compounds",
            "level5": "L01XA04",
            "who_name": "satraplatin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XA",
            "level4_description": "Platinum compounds",
            "level5": "L01XA05",
            "who_name": "polyplatillen"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XB",
            "level4_description": "Methylhydrazines",
            "level5": "L01XB01",
            "who_name": "procarbazine"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XD",
            "level4_description": "Sensitizers used in photodynamic/radiation therapy",
            "level5": "L01XD01",
            "who_name": "porfimer sodium"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XD",
            "level4_description": "Sensitizers used in photodynamic/radiation therapy",
            "level5": "L01XD03",
            "who_name": "methyl aminolevulinate"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XD",
            "level4_description": "Sensitizers used in photodynamic/radiation therapy",
            "level5": "L01XD04",
            "who_name": "aminolevulinic acid"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XD",
            "level4_description": "Sensitizers used in photodynamic/radiation therapy",
            "level5": "L01XD05",
            "who_name": "temoporfin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XD",
            "level4_description": "Sensitizers used in photodynamic/radiation therapy",
            "level5": "L01XD06",
            "who_name": "efaproxiral"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XD",
            "level4_description": "Sensitizers used in photodynamic/radiation therapy",
            "level5": "L01XD07",
            "who_name": "padeliporfin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XF",
            "level4_description": "Retinoids for cancer treatment",
            "level5": "L01XF01",
            "who_name": "tretinoin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XF",
            "level4_description": "Retinoids for cancer treatment",
            "level5": "L01XF02",
            "who_name": "alitretinoin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XF",
            "level4_description": "Retinoids for cancer treatment",
            "level5": "L01XF03",
            "who_name": "bexarotene"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XG",
            "level4_description": "Proteasome inhibitors",
            "level5": "L01XG01",
            "who_name": "bortezomib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XG",
            "level4_description": "Proteasome inhibitors",
            "level5": "L01XG02",
            "who_name": "carfilzomib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XG",
            "level4_description": "Proteasome inhibitors",
            "level5": "L01XG03",
            "who_name": "ixazomib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XH",
            "level4_description": "Histone deacetylase (HDAC) inhibitors",
            "level5": "L01XH01",
            "who_name": "vorinostat"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XH",
            "level4_description": "Histone deacetylase (HDAC) inhibitors",
            "level5": "L01XH02",
            "who_name": "romidepsin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XH",
            "level4_description": "Histone deacetylase (HDAC) inhibitors",
            "level5": "L01XH03",
            "who_name": "panobinostat"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XH",
            "level4_description": "Histone deacetylase (HDAC) inhibitors",
            "level5": "L01XH04",
            "who_name": "belinostat"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XH",
            "level4_description": "Histone deacetylase (HDAC) inhibitors",
            "level5": "L01XH05",
            "who_name": "entinostat"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XJ",
            "level4_description": "Hedgehog pathway inhibitors",
            "level5": "L01XJ01",
            "who_name": "vismodegib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XJ",
            "level4_description": "Hedgehog pathway inhibitors",
            "level5": "L01XJ02",
            "who_name": "sonidegib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XJ",
            "level4_description": "Hedgehog pathway inhibitors",
            "level5": "L01XJ03",
            "who_name": "glasdegib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XK",
            "level4_description": "Poly (ADP-ribose) polymerase (PARP) inhibitors",
            "level5": "L01XK01",
            "who_name": "olaparib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XK",
            "level4_description": "Poly (ADP-ribose) polymerase (PARP) inhibitors",
            "level5": "L01XK02",
            "who_name": "niraparib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XK",
            "level4_description": "Poly (ADP-ribose) polymerase (PARP) inhibitors",
            "level5": "L01XK03",
            "who_name": "rucaparib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XK",
            "level4_description": "Poly (ADP-ribose) polymerase (PARP) inhibitors",
            "level5": "L01XK04",
            "who_name": "talazoparib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XK",
            "level4_description": "Poly (ADP-ribose) polymerase (PARP) inhibitors",
            "level5": "L01XK05",
            "who_name": "veliparib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XK",
            "level4_description": "Poly (ADP-ribose) polymerase (PARP) inhibitors",
            "level5": "L01XK06",
            "who_name": "pamiparib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XX",
            "level4_description": "Other antineoplastic agents",
            "level5": "L01XX01",
            "who_name": "amsacrine"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XX",
            "level4_description": "Other antineoplastic agents",
            "level5": "L01XX02",
            "who_name": "asparaginase"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XX",
            "level4_description": "Other antineoplastic agents",
            "level5": "L01XX03",
            "who_name": "altretamine"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XX",
            "level4_description": "Other antineoplastic agents",
            "level5": "L01XX05",
            "who_name": "hydroxycarbamide"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XX",
            "level4_description": "Other antineoplastic agents",
            "level5": "L01XX07",
            "who_name": "lonidamine"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XX",
            "level4_description": "Other antineoplastic agents",
            "level5": "L01XX08",
            "who_name": "pentostatin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XX",
            "level4_description": "Other antineoplastic agents",
            "level5": "L01XX10",
            "who_name": "masoprocol"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XX",
            "level4_description": "Other antineoplastic agents",
            "level5": "L01XX11",
            "who_name": "estramustine"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XX",
            "level4_description": "Other antineoplastic agents",
            "level5": "L01XX16",
            "who_name": "mitoguazone"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XX",
            "level4_description": "Other antineoplastic agents",
            "level5": "L01XX18",
            "who_name": "tiazofurine"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XX",
            "level4_description": "Other antineoplastic agents",
            "level5": "L01XX23",
            "who_name": "mitotane"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XX",
            "level4_description": "Other antineoplastic agents",
            "level5": "L01XX24",
            "who_name": "pegaspargase"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XX",
            "level4_description": "Other antineoplastic agents",
            "level5": "L01XX27",
            "who_name": "arsenic trioxide"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XX",
            "level4_description": "Other antineoplastic agents",
            "level5": "L01XX29",
            "who_name": "denileukin diftitox"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XX",
            "level4_description": "Other antineoplastic agents",
            "level5": "L01XX33",
            "who_name": "celecoxib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XX",
            "level4_description": "Other antineoplastic agents",
            "level5": "L01XX35",
            "who_name": "anagrelide"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XX",
            "level4_description": "Other antineoplastic agents",
            "level5": "L01XX36",
            "who_name": "oblimersen"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XX",
            "level4_description": "Other antineoplastic agents",
            "level5": "L01XX37",
            "who_name": "sitimagene ceradenovec"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XX",
            "level4_description": "Other antineoplastic agents",
            "level5": "L01XX40",
            "who_name": "omacetaxine mepesuccinate"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XX",
            "level4_description": "Other antineoplastic agents",
            "level5": "L01XX41",
            "who_name": "eribulin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XX",
            "level4_description": "Other antineoplastic agents",
            "level5": "L01XX44",
            "who_name": "aflibercept"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XX",
            "level4_description": "Other antineoplastic agents",
            "level5": "L01XX51",
            "who_name": "talimogene laherparepvec"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XX",
            "level4_description": "Other antineoplastic agents",
            "level5": "L01XX52",
            "who_name": "venetoclax"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XX",
            "level4_description": "Other antineoplastic agents",
            "level5": "L01XX53",
            "who_name": "vosaroxin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XX",
            "level4_description": "Other antineoplastic agents",
            "level5": "L01XX57",
            "who_name": "plitidepsin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XX",
            "level4_description": "Other antineoplastic agents",
            "level5": "L01XX58",
            "who_name": "epacadostat"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XX",
            "level4_description": "Other antineoplastic agents",
            "level5": "L01XX59",
            "who_name": "enasidenib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XX",
            "level4_description": "Other antineoplastic agents",
            "level5": "L01XX62",
            "who_name": "ivosidenib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XX",
            "level4_description": "Other antineoplastic agents",
            "level5": "L01XX66",
            "who_name": "selinexor"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XX",
            "level4_description": "Other antineoplastic agents",
            "level5": "L01XX67",
            "who_name": "tagraxofusp"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XX",
            "level4_description": "Other antineoplastic agents",
            "level5": "L01XX69",
            "who_name": "lurbinectedin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XX",
            "level4_description": "Other antineoplastic agents",
            "level5": "L01XX70",
            "who_name": "axicabtagene ciloleucel"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XX",
            "level4_description": "Other antineoplastic agents",
            "level5": "L01XX71",
            "who_name": "tisagenlecleucel"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XX",
            "level4_description": "Other antineoplastic agents",
            "level5": "L01XX72",
            "who_name": "tazemetostat"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XX",
            "level4_description": "Other antineoplastic agents",
            "level5": "L01XX73",
            "who_name": "sotorasib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XX",
            "level4_description": "Other antineoplastic agents",
            "level5": "L01XX74",
            "who_name": "belzutifan"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XY",
            "level4_description": "Combinations of antineoplastic agents",
            "level5": "L01XY01",
            "who_name": "cytarabine and daunorubicin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01X",
            "level3_description": "OTHER ANTINEOPLASTIC AGENTS",
            "level4": "L01XY",
            "level4_description": "Combinations of antineoplastic agents",
            "level5": "L01XY02",
            "who_name": "pertuzumab and trastuzumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L02",
            "level2_description": "ENDOCRINE THERAPY",
            "level3": "L02A",
            "level3_description": "HORMONES AND RELATED AGENTS",
            "level4": "L02AA",
            "level4_description": "Estrogens",
            "level5": "L02AA01",
            "who_name": "diethylstilbestrol"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L02",
            "level2_description": "ENDOCRINE THERAPY",
            "level3": "L02A",
            "level3_description": "HORMONES AND RELATED AGENTS",
            "level4": "L02AA",
            "level4_description": "Estrogens",
            "level5": "L02AA02",
            "who_name": "polyestradiol phosphate"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L02",
            "level2_description": "ENDOCRINE THERAPY",
            "level3": "L02A",
            "level3_description": "HORMONES AND RELATED AGENTS",
            "level4": "L02AA",
            "level4_description": "Estrogens",
            "level5": "L02AA03",
            "who_name": "ethinylestradiol"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L02",
            "level2_description": "ENDOCRINE THERAPY",
            "level3": "L02A",
            "level3_description": "HORMONES AND RELATED AGENTS",
            "level4": "L02AA",
            "level4_description": "Estrogens",
            "level5": "L02AA04",
            "who_name": "fosfestrol"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L02",
            "level2_description": "ENDOCRINE THERAPY",
            "level3": "L02A",
            "level3_description": "HORMONES AND RELATED AGENTS",
            "level4": "L02AB",
            "level4_description": "Progestogens",
            "level5": "L02AB01",
            "who_name": "megestrol"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L02",
            "level2_description": "ENDOCRINE THERAPY",
            "level3": "L02A",
            "level3_description": "HORMONES AND RELATED AGENTS",
            "level4": "L02AB",
            "level4_description": "Progestogens",
            "level5": "L02AB02",
            "who_name": "medroxyprogesterone"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L02",
            "level2_description": "ENDOCRINE THERAPY",
            "level3": "L02A",
            "level3_description": "HORMONES AND RELATED AGENTS",
            "level4": "L02AB",
            "level4_description": "Progestogens",
            "level5": "L02AB03",
            "who_name": "gestonorone"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L02",
            "level2_description": "ENDOCRINE THERAPY",
            "level3": "L02A",
            "level3_description": "HORMONES AND RELATED AGENTS",
            "level4": "L02AE",
            "level4_description": "Gonadotropin releasing hormone analogues",
            "level5": "L02AE01",
            "who_name": "buserelin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L02",
            "level2_description": "ENDOCRINE THERAPY",
            "level3": "L02A",
            "level3_description": "HORMONES AND RELATED AGENTS",
            "level4": "L02AE",
            "level4_description": "Gonadotropin releasing hormone analogues",
            "level5": "L02AE02",
            "who_name": "leuprorelin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L02",
            "level2_description": "ENDOCRINE THERAPY",
            "level3": "L02A",
            "level3_description": "HORMONES AND RELATED AGENTS",
            "level4": "L02AE",
            "level4_description": "Gonadotropin releasing hormone analogues",
            "level5": "L02AE03",
            "who_name": "goserelin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L02",
            "level2_description": "ENDOCRINE THERAPY",
            "level3": "L02A",
            "level3_description": "HORMONES AND RELATED AGENTS",
            "level4": "L02AE",
            "level4_description": "Gonadotropin releasing hormone analogues",
            "level5": "L02AE04",
            "who_name": "triptorelin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L02",
            "level2_description": "ENDOCRINE THERAPY",
            "level3": "L02A",
            "level3_description": "HORMONES AND RELATED AGENTS",
            "level4": "L02AE",
            "level4_description": "Gonadotropin releasing hormone analogues",
            "level5": "L02AE05",
            "who_name": "histrelin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L02",
            "level2_description": "ENDOCRINE THERAPY",
            "level3": "L02A",
            "level3_description": "HORMONES AND RELATED AGENTS",
            "level4": "L02AE",
            "level4_description": "Gonadotropin releasing hormone analogues",
            "level5": "L02AE51",
            "who_name": "leuprorelin and bicalutamide"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L02",
            "level2_description": "ENDOCRINE THERAPY",
            "level3": "L02B",
            "level3_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
            "level4": "L02BA",
            "level4_description": "Anti-estrogens",
            "level5": "L02BA01",
            "who_name": "tamoxifen"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L02",
            "level2_description": "ENDOCRINE THERAPY",
            "level3": "L02B",
            "level3_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
            "level4": "L02BA",
            "level4_description": "Anti-estrogens",
            "level5": "L02BA02",
            "who_name": "toremifene"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L02",
            "level2_description": "ENDOCRINE THERAPY",
            "level3": "L02B",
            "level3_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
            "level4": "L02BA",
            "level4_description": "Anti-estrogens",
            "level5": "L02BA03",
            "who_name": "fulvestrant"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L02",
            "level2_description": "ENDOCRINE THERAPY",
            "level3": "L02B",
            "level3_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
            "level4": "L02BB",
            "level4_description": "Anti-androgens",
            "level5": "L02BB01",
            "who_name": "flutamide"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L02",
            "level2_description": "ENDOCRINE THERAPY",
            "level3": "L02B",
            "level3_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
            "level4": "L02BB",
            "level4_description": "Anti-androgens",
            "level5": "L02BB02",
            "who_name": "nilutamide"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L02",
            "level2_description": "ENDOCRINE THERAPY",
            "level3": "L02B",
            "level3_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
            "level4": "L02BB",
            "level4_description": "Anti-androgens",
            "level5": "L02BB03",
            "who_name": "bicalutamide"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L02",
            "level2_description": "ENDOCRINE THERAPY",
            "level3": "L02B",
            "level3_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
            "level4": "L02BB",
            "level4_description": "Anti-androgens",
            "level5": "L02BB04",
            "who_name": "enzalutamide"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L02",
            "level2_description": "ENDOCRINE THERAPY",
            "level3": "L02B",
            "level3_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
            "level4": "L02BB",
            "level4_description": "Anti-androgens",
            "level5": "L02BB05",
            "who_name": "apalutamide"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L02",
            "level2_description": "ENDOCRINE THERAPY",
            "level3": "L02B",
            "level3_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
            "level4": "L02BB",
            "level4_description": "Anti-androgens",
            "level5": "L02BB06",
            "who_name": "darolutamide"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L02",
            "level2_description": "ENDOCRINE THERAPY",
            "level3": "L02B",
            "level3_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
            "level4": "L02BG",
            "level4_description": "Aromatase inhibitors",
            "level5": "L02BG01",
            "who_name": "aminoglutethimide"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L02",
            "level2_description": "ENDOCRINE THERAPY",
            "level3": "L02B",
            "level3_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
            "level4": "L02BG",
            "level4_description": "Aromatase inhibitors",
            "level5": "L02BG02",
            "who_name": "formestane"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L02",
            "level2_description": "ENDOCRINE THERAPY",
            "level3": "L02B",
            "level3_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
            "level4": "L02BG",
            "level4_description": "Aromatase inhibitors",
            "level5": "L02BG03",
            "who_name": "anastrozole"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L02",
            "level2_description": "ENDOCRINE THERAPY",
            "level3": "L02B",
            "level3_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
            "level4": "L02BG",
            "level4_description": "Aromatase inhibitors",
            "level5": "L02BG04",
            "who_name": "letrozole"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L02",
            "level2_description": "ENDOCRINE THERAPY",
            "level3": "L02B",
            "level3_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
            "level4": "L02BG",
            "level4_description": "Aromatase inhibitors",
            "level5": "L02BG05",
            "who_name": "vorozole"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L02",
            "level2_description": "ENDOCRINE THERAPY",
            "level3": "L02B",
            "level3_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
            "level4": "L02BG",
            "level4_description": "Aromatase inhibitors",
            "level5": "L02BG06",
            "who_name": "exemestane"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L02",
            "level2_description": "ENDOCRINE THERAPY",
            "level3": "L02B",
            "level3_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
            "level4": "L02BX",
            "level4_description": "Other hormone antagonists and related agents",
            "level5": "L02BX01",
            "who_name": "abarelix"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L02",
            "level2_description": "ENDOCRINE THERAPY",
            "level3": "L02B",
            "level3_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
            "level4": "L02BX",
            "level4_description": "Other hormone antagonists and related agents",
            "level5": "L02BX02",
            "who_name": "degarelix"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L02",
            "level2_description": "ENDOCRINE THERAPY",
            "level3": "L02B",
            "level3_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
            "level4": "L02BX",
            "level4_description": "Other hormone antagonists and related agents",
            "level5": "L02BX03",
            "who_name": "abiraterone"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L02",
            "level2_description": "ENDOCRINE THERAPY",
            "level3": "L02B",
            "level3_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
            "level4": "L02BX",
            "level4_description": "Other hormone antagonists and related agents",
            "level5": "L02BX04",
            "who_name": "relugolix"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AA",
            "level4_description": "Colony stimulating factors",
            "level5": "L03AA02",
            "who_name": "filgrastim"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AA",
            "level4_description": "Colony stimulating factors",
            "level5": "L03AA03",
            "who_name": "molgramostim"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AA",
            "level4_description": "Colony stimulating factors",
            "level5": "L03AA09",
            "who_name": "sargramostim"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AA",
            "level4_description": "Colony stimulating factors",
            "level5": "L03AA10",
            "who_name": "lenograstim"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AA",
            "level4_description": "Colony stimulating factors",
            "level5": "L03AA12",
            "who_name": "ancestim"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AA",
            "level4_description": "Colony stimulating factors",
            "level5": "L03AA13",
            "who_name": "pegfilgrastim"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AA",
            "level4_description": "Colony stimulating factors",
            "level5": "L03AA14",
            "who_name": "lipegfilgrastim"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AA",
            "level4_description": "Colony stimulating factors",
            "level5": "L03AA15",
            "who_name": "balugrastim"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AA",
            "level4_description": "Colony stimulating factors",
            "level5": "L03AA16",
            "who_name": "empegfilgrastim"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AA",
            "level4_description": "Colony stimulating factors",
            "level5": "L03AA17",
            "who_name": "pegteograstim"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AB",
            "level4_description": "Interferons",
            "level5": "L03AB01",
            "who_name": "interferon alfa natural"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AB",
            "level4_description": "Interferons",
            "level5": "L03AB02",
            "who_name": "interferon beta natural"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AB",
            "level4_description": "Interferons",
            "level5": "L03AB03",
            "who_name": "interferon gamma"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AB",
            "level4_description": "Interferons",
            "level5": "L03AB04",
            "who_name": "interferon alfa-2a"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AB",
            "level4_description": "Interferons",
            "level5": "L03AB05",
            "who_name": "interferon alfa-2b"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AB",
            "level4_description": "Interferons",
            "level5": "L03AB06",
            "who_name": "interferon alfa-n1"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AB",
            "level4_description": "Interferons",
            "level5": "L03AB07",
            "who_name": "interferon beta-1a"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AB",
            "level4_description": "Interferons",
            "level5": "L03AB08",
            "who_name": "interferon beta-1b"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AB",
            "level4_description": "Interferons",
            "level5": "L03AB09",
            "who_name": "interferon alfacon-1"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AB",
            "level4_description": "Interferons",
            "level5": "L03AB10",
            "who_name": "peginterferon alfa-2b"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AB",
            "level4_description": "Interferons",
            "level5": "L03AB11",
            "who_name": "peginterferon alfa-2a"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AB",
            "level4_description": "Interferons",
            "level5": "L03AB12",
            "who_name": "albinterferon alfa-2b"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AB",
            "level4_description": "Interferons",
            "level5": "L03AB13",
            "who_name": "peginterferon beta-1a"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AB",
            "level4_description": "Interferons",
            "level5": "L03AB14",
            "who_name": "cepeginterferon alfa-2b"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AB",
            "level4_description": "Interferons",
            "level5": "L03AB15",
            "who_name": "ropeginterferon alfa-2b"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AB",
            "level4_description": "Interferons",
            "level5": "L03AB16",
            "who_name": "peginterferon alfacon-2"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AB",
            "level4_description": "Interferons",
            "level5": "L03AB60",
            "who_name": "peginterferon alfa-2b, combinations"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AB",
            "level4_description": "Interferons",
            "level5": "L03AB61",
            "who_name": "peginterferon alfa-2a, combinations"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AC",
            "level4_description": "Interleukins",
            "level5": "L03AC01",
            "who_name": "aldesleukin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AC",
            "level4_description": "Interleukins",
            "level5": "L03AC02",
            "who_name": "oprelvekin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AX",
            "level4_description": "Other immunostimulants",
            "level5": "L03AX01",
            "who_name": "lentinan"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AX",
            "level4_description": "Other immunostimulants",
            "level5": "L03AX02",
            "who_name": "roquinimex"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AX",
            "level4_description": "Other immunostimulants",
            "level5": "L03AX03",
            "who_name": "BCG vaccine"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AX",
            "level4_description": "Other immunostimulants",
            "level5": "L03AX04",
            "who_name": "pegademase"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AX",
            "level4_description": "Other immunostimulants",
            "level5": "L03AX05",
            "who_name": "pidotimod"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AX",
            "level4_description": "Other immunostimulants",
            "level5": "L03AX07",
            "who_name": "poly I:C"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AX",
            "level4_description": "Other immunostimulants",
            "level5": "L03AX08",
            "who_name": "poly ICLC"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AX",
            "level4_description": "Other immunostimulants",
            "level5": "L03AX09",
            "who_name": "thymopentin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AX",
            "level4_description": "Other immunostimulants",
            "level5": "L03AX10",
            "who_name": "immunocyanin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AX",
            "level4_description": "Other immunostimulants",
            "level5": "L03AX11",
            "who_name": "tasonermin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AX",
            "level4_description": "Other immunostimulants",
            "level5": "L03AX12",
            "who_name": "melanoma vaccine"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AX",
            "level4_description": "Other immunostimulants",
            "level5": "L03AX13",
            "who_name": "glatiramer acetate"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AX",
            "level4_description": "Other immunostimulants",
            "level5": "L03AX14",
            "who_name": "histamine dihydrochloride"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AX",
            "level4_description": "Other immunostimulants",
            "level5": "L03AX15",
            "who_name": "mifamurtide"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AX",
            "level4_description": "Other immunostimulants",
            "level5": "L03AX16",
            "who_name": "plerixafor"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AX",
            "level4_description": "Other immunostimulants",
            "level5": "L03AX17",
            "who_name": "sipuleucel-T"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AX",
            "level4_description": "Other immunostimulants",
            "level5": "L03AX18",
            "who_name": "cridanimod"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AX",
            "level4_description": "Other immunostimulants",
            "level5": "L03AX19",
            "who_name": "dasiprotimut-T"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L03",
            "level2_description": "IMMUNOSTIMULANTS",
            "level3": "L03A",
            "level3_description": "IMMUNOSTIMULANTS",
            "level4": "L03AX",
            "level4_description": "Other immunostimulants",
            "level5": "L03AX21",
            "who_name": "elapegademase"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AA",
            "level4_description": "Selective immunosuppressants",
            "level5": "L04AA02",
            "who_name": "muromonab-CD3"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AA",
            "level4_description": "Selective immunosuppressants",
            "level5": "L04AA03",
            "who_name": "antilymphocyte immunoglobulin (horse)"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AA",
            "level4_description": "Selective immunosuppressants",
            "level5": "L04AA04",
            "who_name": "antithymocyte immunoglobulin (rabbit)"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AA",
            "level4_description": "Selective immunosuppressants",
            "level5": "L04AA06",
            "who_name": "mycophenolic acid"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AA",
            "level4_description": "Selective immunosuppressants",
            "level5": "L04AA10",
            "who_name": "sirolimus"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AA",
            "level4_description": "Selective immunosuppressants",
            "level5": "L04AA13",
            "who_name": "leflunomide"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AA",
            "level4_description": "Selective immunosuppressants",
            "level5": "L04AA15",
            "who_name": "alefacept"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AA",
            "level4_description": "Selective immunosuppressants",
            "level5": "L04AA18",
            "who_name": "everolimus"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AA",
            "level4_description": "Selective immunosuppressants",
            "level5": "L04AA19",
            "who_name": "gusperimus"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AA",
            "level4_description": "Selective immunosuppressants",
            "level5": "L04AA21",
            "who_name": "efalizumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AA",
            "level4_description": "Selective immunosuppressants",
            "level5": "L04AA22",
            "who_name": "abetimus"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AA",
            "level4_description": "Selective immunosuppressants",
            "level5": "L04AA23",
            "who_name": "natalizumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AA",
            "level4_description": "Selective immunosuppressants",
            "level5": "L04AA24",
            "who_name": "abatacept"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AA",
            "level4_description": "Selective immunosuppressants",
            "level5": "L04AA25",
            "who_name": "eculizumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AA",
            "level4_description": "Selective immunosuppressants",
            "level5": "L04AA26",
            "who_name": "belimumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AA",
            "level4_description": "Selective immunosuppressants",
            "level5": "L04AA27",
            "who_name": "fingolimod"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AA",
            "level4_description": "Selective immunosuppressants",
            "level5": "L04AA28",
            "who_name": "belatacept"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AA",
            "level4_description": "Selective immunosuppressants",
            "level5": "L04AA29",
            "who_name": "tofacitinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AA",
            "level4_description": "Selective immunosuppressants",
            "level5": "L04AA31",
            "who_name": "teriflunomide"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AA",
            "level4_description": "Selective immunosuppressants",
            "level5": "L04AA32",
            "who_name": "apremilast"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AA",
            "level4_description": "Selective immunosuppressants",
            "level5": "L04AA33",
            "who_name": "vedolizumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AA",
            "level4_description": "Selective immunosuppressants",
            "level5": "L04AA34",
            "who_name": "alemtuzumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AA",
            "level4_description": "Selective immunosuppressants",
            "level5": "L04AA35",
            "who_name": "begelomab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AA",
            "level4_description": "Selective immunosuppressants",
            "level5": "L04AA36",
            "who_name": "ocrelizumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AA",
            "level4_description": "Selective immunosuppressants",
            "level5": "L04AA37",
            "who_name": "baricitinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AA",
            "level4_description": "Selective immunosuppressants",
            "level5": "L04AA38",
            "who_name": "ozanimod"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AA",
            "level4_description": "Selective immunosuppressants",
            "level5": "L04AA39",
            "who_name": "emapalumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AA",
            "level4_description": "Selective immunosuppressants",
            "level5": "L04AA40",
            "who_name": "cladribine"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AA",
            "level4_description": "Selective immunosuppressants",
            "level5": "L04AA41",
            "who_name": "imlifidase"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AA",
            "level4_description": "Selective immunosuppressants",
            "level5": "L04AA42",
            "who_name": "siponimod"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AA",
            "level4_description": "Selective immunosuppressants",
            "level5": "L04AA43",
            "who_name": "ravulizumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AA",
            "level4_description": "Selective immunosuppressants",
            "level5": "L04AA44",
            "who_name": "upadacitinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AA",
            "level4_description": "Selective immunosuppressants",
            "level5": "L04AA45",
            "who_name": "filgotinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AA",
            "level4_description": "Selective immunosuppressants",
            "level5": "L04AA46",
            "who_name": "itacitinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AA",
            "level4_description": "Selective immunosuppressants",
            "level5": "L04AA47",
            "who_name": "inebilizumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AA",
            "level4_description": "Selective immunosuppressants",
            "level5": "L04AA48",
            "who_name": "belumosudil"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AA",
            "level4_description": "Selective immunosuppressants",
            "level5": "L04AA49",
            "who_name": "peficitinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AA",
            "level4_description": "Selective immunosuppressants",
            "level5": "L04AA50",
            "who_name": "ponesimod"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AA",
            "level4_description": "Selective immunosuppressants",
            "level5": "L04AA51",
            "who_name": "anifrolumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AA",
            "level4_description": "Selective immunosuppressants",
            "level5": "L04AA52",
            "who_name": "ofatumumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AA",
            "level4_description": "Selective immunosuppressants",
            "level5": "L04AA53",
            "who_name": "teprotumumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AA",
            "level4_description": "Selective immunosuppressants",
            "level5": "L04AA54",
            "who_name": "pegcetacoplan"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AA",
            "level4_description": "Selective immunosuppressants",
            "level5": "L04AA55",
            "who_name": "sutimlimab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AA",
            "level4_description": "Selective immunosuppressants",
            "level5": "L04AA56",
            "who_name": "deucravacitinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AB",
            "level4_description": "Tumor necrosis factor alpha (TNF-alpha) inhibitors",
            "level5": "L04AB01",
            "who_name": "etanercept"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AB",
            "level4_description": "Tumor necrosis factor alpha (TNF-alpha) inhibitors",
            "level5": "L04AB02",
            "who_name": "infliximab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AB",
            "level4_description": "Tumor necrosis factor alpha (TNF-alpha) inhibitors",
            "level5": "L04AB03",
            "who_name": "afelimomab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AB",
            "level4_description": "Tumor necrosis factor alpha (TNF-alpha) inhibitors",
            "level5": "L04AB04",
            "who_name": "adalimumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AB",
            "level4_description": "Tumor necrosis factor alpha (TNF-alpha) inhibitors",
            "level5": "L04AB05",
            "who_name": "certolizumab pegol"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AB",
            "level4_description": "Tumor necrosis factor alpha (TNF-alpha) inhibitors",
            "level5": "L04AB06",
            "who_name": "golimumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AB",
            "level4_description": "Tumor necrosis factor alpha (TNF-alpha) inhibitors",
            "level5": "L04AB07",
            "who_name": "opinercept"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AC",
            "level4_description": "Interleukin inhibitors",
            "level5": "L04AC01",
            "who_name": "daclizumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AC",
            "level4_description": "Interleukin inhibitors",
            "level5": "L04AC02",
            "who_name": "basiliximab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AC",
            "level4_description": "Interleukin inhibitors",
            "level5": "L04AC03",
            "who_name": "anakinra"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AC",
            "level4_description": "Interleukin inhibitors",
            "level5": "L04AC04",
            "who_name": "rilonacept"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AC",
            "level4_description": "Interleukin inhibitors",
            "level5": "L04AC05",
            "who_name": "ustekinumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AC",
            "level4_description": "Interleukin inhibitors",
            "level5": "L04AC07",
            "who_name": "tocilizumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AC",
            "level4_description": "Interleukin inhibitors",
            "level5": "L04AC08",
            "who_name": "canakinumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AC",
            "level4_description": "Interleukin inhibitors",
            "level5": "L04AC09",
            "who_name": "briakinumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AC",
            "level4_description": "Interleukin inhibitors",
            "level5": "L04AC10",
            "who_name": "secukinumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AC",
            "level4_description": "Interleukin inhibitors",
            "level5": "L04AC11",
            "who_name": "siltuximab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AC",
            "level4_description": "Interleukin inhibitors",
            "level5": "L04AC12",
            "who_name": "brodalumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AC",
            "level4_description": "Interleukin inhibitors",
            "level5": "L04AC13",
            "who_name": "ixekizumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AC",
            "level4_description": "Interleukin inhibitors",
            "level5": "L04AC14",
            "who_name": "sarilumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AC",
            "level4_description": "Interleukin inhibitors",
            "level5": "L04AC15",
            "who_name": "sirukumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AC",
            "level4_description": "Interleukin inhibitors",
            "level5": "L04AC16",
            "who_name": "guselkumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AC",
            "level4_description": "Interleukin inhibitors",
            "level5": "L04AC17",
            "who_name": "tildrakizumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AC",
            "level4_description": "Interleukin inhibitors",
            "level5": "L04AC18",
            "who_name": "risankizumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AC",
            "level4_description": "Interleukin inhibitors",
            "level5": "L04AC19",
            "who_name": "satralizumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AC",
            "level4_description": "Interleukin inhibitors",
            "level5": "L04AC20",
            "who_name": "netakimab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AC",
            "level4_description": "Interleukin inhibitors",
            "level5": "L04AC21",
            "who_name": "bimekizumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AC",
            "level4_description": "Interleukin inhibitors",
            "level5": "L04AC22",
            "who_name": "spesolimab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AD",
            "level4_description": "Calcineurin inhibitors",
            "level5": "L04AD01",
            "who_name": "ciclosporin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AD",
            "level4_description": "Calcineurin inhibitors",
            "level5": "L04AD02",
            "who_name": "tacrolimus"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AD",
            "level4_description": "Calcineurin inhibitors",
            "level5": "L04AD03",
            "who_name": "voclosporin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AX",
            "level4_description": "Other immunosuppressants",
            "level5": "L04AX01",
            "who_name": "azathioprine"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AX",
            "level4_description": "Other immunosuppressants",
            "level5": "L04AX02",
            "who_name": "thalidomide"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AX",
            "level4_description": "Other immunosuppressants",
            "level5": "L04AX03",
            "who_name": "methotrexate"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AX",
            "level4_description": "Other immunosuppressants",
            "level5": "L04AX04",
            "who_name": "lenalidomide"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AX",
            "level4_description": "Other immunosuppressants",
            "level5": "L04AX05",
            "who_name": "pirfenidone"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AX",
            "level4_description": "Other immunosuppressants",
            "level5": "L04AX06",
            "who_name": "pomalidomide"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AX",
            "level4_description": "Other immunosuppressants",
            "level5": "L04AX07",
            "who_name": "dimethyl fumarate"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AX",
            "level4_description": "Other immunosuppressants",
            "level5": "L04AX08",
            "who_name": "darvadstrocel"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L04",
            "level2_description": "IMMUNOSUPPRESSANTS",
            "level3": "L04A",
            "level3_description": "IMMUNOSUPPRESSANTS",
            "level4": "L04AX",
            "level4_description": "Other immunosuppressants",
            "level5": "L04AX09",
            "who_name": "diroximel fumarate"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AA",
            "level4_description": "Butylpyrazolidines",
            "level5": "M01AA01",
            "who_name": "phenylbutazone"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AA",
            "level4_description": "Butylpyrazolidines",
            "level5": "M01AA02",
            "who_name": "mofebutazone"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AA",
            "level4_description": "Butylpyrazolidines",
            "level5": "M01AA03",
            "who_name": "oxyphenbutazone"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AA",
            "level4_description": "Butylpyrazolidines",
            "level5": "M01AA05",
            "who_name": "clofezone"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AA",
            "level4_description": "Butylpyrazolidines",
            "level5": "M01AA06",
            "who_name": "kebuzone"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AB",
            "level4_description": "Acetic acid derivatives and related substances",
            "level5": "M01AB01",
            "who_name": "indometacin"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AB",
            "level4_description": "Acetic acid derivatives and related substances",
            "level5": "M01AB02",
            "who_name": "sulindac"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AB",
            "level4_description": "Acetic acid derivatives and related substances",
            "level5": "M01AB03",
            "who_name": "tolmetin"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AB",
            "level4_description": "Acetic acid derivatives and related substances",
            "level5": "M01AB04",
            "who_name": "zomepirac"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AB",
            "level4_description": "Acetic acid derivatives and related substances",
            "level5": "M01AB05",
            "who_name": "diclofenac"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AB",
            "level4_description": "Acetic acid derivatives and related substances",
            "level5": "M01AB06",
            "who_name": "alclofenac"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AB",
            "level4_description": "Acetic acid derivatives and related substances",
            "level5": "M01AB07",
            "who_name": "bumadizone"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AB",
            "level4_description": "Acetic acid derivatives and related substances",
            "level5": "M01AB08",
            "who_name": "etodolac"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AB",
            "level4_description": "Acetic acid derivatives and related substances",
            "level5": "M01AB09",
            "who_name": "lonazolac"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AB",
            "level4_description": "Acetic acid derivatives and related substances",
            "level5": "M01AB10",
            "who_name": "fentiazac"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AB",
            "level4_description": "Acetic acid derivatives and related substances",
            "level5": "M01AB11",
            "who_name": "acemetacin"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AB",
            "level4_description": "Acetic acid derivatives and related substances",
            "level5": "M01AB12",
            "who_name": "difenpiramide"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AB",
            "level4_description": "Acetic acid derivatives and related substances",
            "level5": "M01AB13",
            "who_name": "oxametacin"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AB",
            "level4_description": "Acetic acid derivatives and related substances",
            "level5": "M01AB14",
            "who_name": "proglumetacin"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AB",
            "level4_description": "Acetic acid derivatives and related substances",
            "level5": "M01AB15",
            "who_name": "ketorolac"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AB",
            "level4_description": "Acetic acid derivatives and related substances",
            "level5": "M01AB16",
            "who_name": "aceclofenac"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AB",
            "level4_description": "Acetic acid derivatives and related substances",
            "level5": "M01AB17",
            "who_name": "bufexamac"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AB",
            "level4_description": "Acetic acid derivatives and related substances",
            "level5": "M01AB51",
            "who_name": "indometacin, combinations"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AB",
            "level4_description": "Acetic acid derivatives and related substances",
            "level5": "M01AB55",
            "who_name": "diclofenac, combinations"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AC",
            "level4_description": "Oxicams",
            "level5": "M01AC01",
            "who_name": "piroxicam"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AC",
            "level4_description": "Oxicams",
            "level5": "M01AC02",
            "who_name": "tenoxicam"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AC",
            "level4_description": "Oxicams",
            "level5": "M01AC04",
            "who_name": "droxicam"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AC",
            "level4_description": "Oxicams",
            "level5": "M01AC05",
            "who_name": "lornoxicam"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AC",
            "level4_description": "Oxicams",
            "level5": "M01AC06",
            "who_name": "meloxicam"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AC",
            "level4_description": "Oxicams",
            "level5": "M01AC56",
            "who_name": "meloxicam, combinations"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AE",
            "level4_description": "Propionic acid derivatives",
            "level5": "M01AE01",
            "who_name": "ibuprofen"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AE",
            "level4_description": "Propionic acid derivatives",
            "level5": "M01AE02",
            "who_name": "naproxen"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AE",
            "level4_description": "Propionic acid derivatives",
            "level5": "M01AE03",
            "who_name": "ketoprofen"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AE",
            "level4_description": "Propionic acid derivatives",
            "level5": "M01AE04",
            "who_name": "fenoprofen"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AE",
            "level4_description": "Propionic acid derivatives",
            "level5": "M01AE05",
            "who_name": "fenbufen"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AE",
            "level4_description": "Propionic acid derivatives",
            "level5": "M01AE06",
            "who_name": "benoxaprofen"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AE",
            "level4_description": "Propionic acid derivatives",
            "level5": "M01AE07",
            "who_name": "suprofen"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AE",
            "level4_description": "Propionic acid derivatives",
            "level5": "M01AE08",
            "who_name": "pirprofen"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AE",
            "level4_description": "Propionic acid derivatives",
            "level5": "M01AE09",
            "who_name": "flurbiprofen"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AE",
            "level4_description": "Propionic acid derivatives",
            "level5": "M01AE10",
            "who_name": "indoprofen"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AE",
            "level4_description": "Propionic acid derivatives",
            "level5": "M01AE11",
            "who_name": "tiaprofenic acid"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AE",
            "level4_description": "Propionic acid derivatives",
            "level5": "M01AE12",
            "who_name": "oxaprozin"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AE",
            "level4_description": "Propionic acid derivatives",
            "level5": "M01AE13",
            "who_name": "ibuproxam"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AE",
            "level4_description": "Propionic acid derivatives",
            "level5": "M01AE14",
            "who_name": "dexibuprofen"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AE",
            "level4_description": "Propionic acid derivatives",
            "level5": "M01AE15",
            "who_name": "flunoxaprofen"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AE",
            "level4_description": "Propionic acid derivatives",
            "level5": "M01AE16",
            "who_name": "alminoprofen"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AE",
            "level4_description": "Propionic acid derivatives",
            "level5": "M01AE17",
            "who_name": "dexketoprofen"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AE",
            "level4_description": "Propionic acid derivatives",
            "level5": "M01AE18",
            "who_name": "naproxcinod"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AE",
            "level4_description": "Propionic acid derivatives",
            "level5": "M01AE51",
            "who_name": "ibuprofen, combinations"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AE",
            "level4_description": "Propionic acid derivatives",
            "level5": "M01AE52",
            "who_name": "naproxen and esomeprazole"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AE",
            "level4_description": "Propionic acid derivatives",
            "level5": "M01AE53",
            "who_name": "ketoprofen, combinations"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AE",
            "level4_description": "Propionic acid derivatives",
            "level5": "M01AE56",
            "who_name": "naproxen and misoprostol"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AG",
            "level4_description": "Fenamates",
            "level5": "M01AG01",
            "who_name": "mefenamic acid"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AG",
            "level4_description": "Fenamates",
            "level5": "M01AG02",
            "who_name": "tolfenamic acid"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AG",
            "level4_description": "Fenamates",
            "level5": "M01AG03",
            "who_name": "flufenamic acid"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AG",
            "level4_description": "Fenamates",
            "level5": "M01AG04",
            "who_name": "meclofenamic acid"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AH",
            "level4_description": "Coxibs",
            "level5": "M01AH01",
            "who_name": "celecoxib"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AH",
            "level4_description": "Coxibs",
            "level5": "M01AH02",
            "who_name": "rofecoxib"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AH",
            "level4_description": "Coxibs",
            "level5": "M01AH03",
            "who_name": "valdecoxib"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AH",
            "level4_description": "Coxibs",
            "level5": "M01AH04",
            "who_name": "parecoxib"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AH",
            "level4_description": "Coxibs",
            "level5": "M01AH05",
            "who_name": "etoricoxib"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AH",
            "level4_description": "Coxibs",
            "level5": "M01AH06",
            "who_name": "lumiracoxib"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AH",
            "level4_description": "Coxibs",
            "level5": "M01AH07",
            "who_name": "polmacoxib"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AX",
            "level4_description": "Other antiinflammatory and antirheumatic agents, non-steroids",
            "level5": "M01AX01",
            "who_name": "nabumetone"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AX",
            "level4_description": "Other antiinflammatory and antirheumatic agents, non-steroids",
            "level5": "M01AX02",
            "who_name": "niflumic acid"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AX",
            "level4_description": "Other antiinflammatory and antirheumatic agents, non-steroids",
            "level5": "M01AX04",
            "who_name": "azapropazone"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AX",
            "level4_description": "Other antiinflammatory and antirheumatic agents, non-steroids",
            "level5": "M01AX05",
            "who_name": "glucosamine"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AX",
            "level4_description": "Other antiinflammatory and antirheumatic agents, non-steroids",
            "level5": "M01AX07",
            "who_name": "benzydamine"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AX",
            "level4_description": "Other antiinflammatory and antirheumatic agents, non-steroids",
            "level5": "M01AX12",
            "who_name": "glucosaminoglycan polysulfate"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AX",
            "level4_description": "Other antiinflammatory and antirheumatic agents, non-steroids",
            "level5": "M01AX13",
            "who_name": "proquazone"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AX",
            "level4_description": "Other antiinflammatory and antirheumatic agents, non-steroids",
            "level5": "M01AX14",
            "who_name": "orgotein"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AX",
            "level4_description": "Other antiinflammatory and antirheumatic agents, non-steroids",
            "level5": "M01AX17",
            "who_name": "nimesulide"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AX",
            "level4_description": "Other antiinflammatory and antirheumatic agents, non-steroids",
            "level5": "M01AX18",
            "who_name": "feprazone"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AX",
            "level4_description": "Other antiinflammatory and antirheumatic agents, non-steroids",
            "level5": "M01AX21",
            "who_name": "diacerein"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AX",
            "level4_description": "Other antiinflammatory and antirheumatic agents, non-steroids",
            "level5": "M01AX22",
            "who_name": "morniflumate"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AX",
            "level4_description": "Other antiinflammatory and antirheumatic agents, non-steroids",
            "level5": "M01AX23",
            "who_name": "tenidap"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AX",
            "level4_description": "Other antiinflammatory and antirheumatic agents, non-steroids",
            "level5": "M01AX24",
            "who_name": "oxaceprol"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AX",
            "level4_description": "Other antiinflammatory and antirheumatic agents, non-steroids",
            "level5": "M01AX25",
            "who_name": "chondroitin sulfate"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AX",
            "level4_description": "Other antiinflammatory and antirheumatic agents, non-steroids",
            "level5": "M01AX26",
            "who_name": "avocado and soyabean oil, unsaponifiables"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01A",
            "level3_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS",
            "level4": "M01AX",
            "level4_description": "Other antiinflammatory and antirheumatic agents, non-steroids",
            "level5": "M01AX68",
            "who_name": "feprazone, combinations"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01B",
            "level3_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC AGENTS IN COMBINATION",
            "level4": "M01BA",
            "level4_description": "Antiinflammatory/antirheumatic agents in combination with corticosteroids",
            "level5": "M01BA01",
            "who_name": "phenylbutazone and corticosteroids"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01B",
            "level3_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC AGENTS IN COMBINATION",
            "level4": "M01BA",
            "level4_description": "Antiinflammatory/antirheumatic agents in combination with corticosteroids",
            "level5": "M01BA02",
            "who_name": "dipyrocetyl and corticosteroids"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01B",
            "level3_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC AGENTS IN COMBINATION",
            "level4": "M01BA",
            "level4_description": "Antiinflammatory/antirheumatic agents in combination with corticosteroids",
            "level5": "M01BA03",
            "who_name": "acetylsalicylic acid and corticosteroids"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01C",
            "level3_description": "SPECIFIC ANTIRHEUMATIC AGENTS",
            "level4": "M01CA",
            "level4_description": "Quinolines",
            "level5": "M01CA03",
            "who_name": "oxycinchophen"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01C",
            "level3_description": "SPECIFIC ANTIRHEUMATIC AGENTS",
            "level4": "M01CB",
            "level4_description": "Gold preparations",
            "level5": "M01CB01",
            "who_name": "sodium aurothiomalate"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01C",
            "level3_description": "SPECIFIC ANTIRHEUMATIC AGENTS",
            "level4": "M01CB",
            "level4_description": "Gold preparations",
            "level5": "M01CB02",
            "who_name": "sodium aurotiosulfate"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01C",
            "level3_description": "SPECIFIC ANTIRHEUMATIC AGENTS",
            "level4": "M01CB",
            "level4_description": "Gold preparations",
            "level5": "M01CB03",
            "who_name": "auranofin"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01C",
            "level3_description": "SPECIFIC ANTIRHEUMATIC AGENTS",
            "level4": "M01CB",
            "level4_description": "Gold preparations",
            "level5": "M01CB04",
            "who_name": "aurothioglucose"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01C",
            "level3_description": "SPECIFIC ANTIRHEUMATIC AGENTS",
            "level4": "M01CB",
            "level4_description": "Gold preparations",
            "level5": "M01CB05",
            "who_name": "aurotioprol"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01C",
            "level3_description": "SPECIFIC ANTIRHEUMATIC AGENTS",
            "level4": "M01CC",
            "level4_description": "Penicillamine and similar agents",
            "level5": "M01CC01",
            "who_name": "penicillamine"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M01",
            "level2_description": "ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS",
            "level3": "M01C",
            "level3_description": "SPECIFIC ANTIRHEUMATIC AGENTS",
            "level4": "M01CC",
            "level4_description": "Penicillamine and similar agents",
            "level5": "M01CC02",
            "who_name": "bucillamine"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M02",
            "level2_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level3": "M02A",
            "level3_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level4": "M02AA",
            "level4_description": "Antiinflammatory preparations, non-steroids for topical use",
            "level5": "M02AA01",
            "who_name": "phenylbutazone"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M02",
            "level2_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level3": "M02A",
            "level3_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level4": "M02AA",
            "level4_description": "Antiinflammatory preparations, non-steroids for topical use",
            "level5": "M02AA02",
            "who_name": "mofebutazone"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M02",
            "level2_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level3": "M02A",
            "level3_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level4": "M02AA",
            "level4_description": "Antiinflammatory preparations, non-steroids for topical use",
            "level5": "M02AA03",
            "who_name": "clofezone"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M02",
            "level2_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level3": "M02A",
            "level3_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level4": "M02AA",
            "level4_description": "Antiinflammatory preparations, non-steroids for topical use",
            "level5": "M02AA04",
            "who_name": "oxyphenbutazone"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M02",
            "level2_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level3": "M02A",
            "level3_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level4": "M02AA",
            "level4_description": "Antiinflammatory preparations, non-steroids for topical use",
            "level5": "M02AA05",
            "who_name": "benzydamine"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M02",
            "level2_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level3": "M02A",
            "level3_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level4": "M02AA",
            "level4_description": "Antiinflammatory preparations, non-steroids for topical use",
            "level5": "M02AA06",
            "who_name": "etofenamate"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M02",
            "level2_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level3": "M02A",
            "level3_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level4": "M02AA",
            "level4_description": "Antiinflammatory preparations, non-steroids for topical use",
            "level5": "M02AA07",
            "who_name": "piroxicam"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M02",
            "level2_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level3": "M02A",
            "level3_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level4": "M02AA",
            "level4_description": "Antiinflammatory preparations, non-steroids for topical use",
            "level5": "M02AA08",
            "who_name": "felbinac"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M02",
            "level2_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level3": "M02A",
            "level3_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level4": "M02AA",
            "level4_description": "Antiinflammatory preparations, non-steroids for topical use",
            "level5": "M02AA09",
            "who_name": "bufexamac"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M02",
            "level2_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level3": "M02A",
            "level3_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level4": "M02AA",
            "level4_description": "Antiinflammatory preparations, non-steroids for topical use",
            "level5": "M02AA10",
            "who_name": "ketoprofen"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M02",
            "level2_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level3": "M02A",
            "level3_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level4": "M02AA",
            "level4_description": "Antiinflammatory preparations, non-steroids for topical use",
            "level5": "M02AA11",
            "who_name": "bendazac"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M02",
            "level2_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level3": "M02A",
            "level3_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level4": "M02AA",
            "level4_description": "Antiinflammatory preparations, non-steroids for topical use",
            "level5": "M02AA12",
            "who_name": "naproxen"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M02",
            "level2_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level3": "M02A",
            "level3_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level4": "M02AA",
            "level4_description": "Antiinflammatory preparations, non-steroids for topical use",
            "level5": "M02AA13",
            "who_name": "ibuprofen"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M02",
            "level2_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level3": "M02A",
            "level3_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level4": "M02AA",
            "level4_description": "Antiinflammatory preparations, non-steroids for topical use",
            "level5": "M02AA14",
            "who_name": "fentiazac"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M02",
            "level2_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level3": "M02A",
            "level3_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level4": "M02AA",
            "level4_description": "Antiinflammatory preparations, non-steroids for topical use",
            "level5": "M02AA15",
            "who_name": "diclofenac"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M02",
            "level2_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level3": "M02A",
            "level3_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level4": "M02AA",
            "level4_description": "Antiinflammatory preparations, non-steroids for topical use",
            "level5": "M02AA16",
            "who_name": "feprazone"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M02",
            "level2_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level3": "M02A",
            "level3_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level4": "M02AA",
            "level4_description": "Antiinflammatory preparations, non-steroids for topical use",
            "level5": "M02AA17",
            "who_name": "niflumic acid"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M02",
            "level2_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level3": "M02A",
            "level3_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level4": "M02AA",
            "level4_description": "Antiinflammatory preparations, non-steroids for topical use",
            "level5": "M02AA18",
            "who_name": "meclofenamic acid"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M02",
            "level2_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level3": "M02A",
            "level3_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level4": "M02AA",
            "level4_description": "Antiinflammatory preparations, non-steroids for topical use",
            "level5": "M02AA19",
            "who_name": "flurbiprofen"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M02",
            "level2_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level3": "M02A",
            "level3_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level4": "M02AA",
            "level4_description": "Antiinflammatory preparations, non-steroids for topical use",
            "level5": "M02AA21",
            "who_name": "tolmetin"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M02",
            "level2_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level3": "M02A",
            "level3_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level4": "M02AA",
            "level4_description": "Antiinflammatory preparations, non-steroids for topical use",
            "level5": "M02AA22",
            "who_name": "suxibuzone"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M02",
            "level2_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level3": "M02A",
            "level3_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level4": "M02AA",
            "level4_description": "Antiinflammatory preparations, non-steroids for topical use",
            "level5": "M02AA23",
            "who_name": "indometacin"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M02",
            "level2_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level3": "M02A",
            "level3_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level4": "M02AA",
            "level4_description": "Antiinflammatory preparations, non-steroids for topical use",
            "level5": "M02AA24",
            "who_name": "nifenazone"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M02",
            "level2_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level3": "M02A",
            "level3_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level4": "M02AA",
            "level4_description": "Antiinflammatory preparations, non-steroids for topical use",
            "level5": "M02AA25",
            "who_name": "aceclofenac"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M02",
            "level2_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level3": "M02A",
            "level3_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level4": "M02AA",
            "level4_description": "Antiinflammatory preparations, non-steroids for topical use",
            "level5": "M02AA26",
            "who_name": "nimesulide"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M02",
            "level2_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level3": "M02A",
            "level3_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level4": "M02AA",
            "level4_description": "Antiinflammatory preparations, non-steroids for topical use",
            "level5": "M02AA27",
            "who_name": "dexketoprofen"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M02",
            "level2_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level3": "M02A",
            "level3_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level4": "M02AA",
            "level4_description": "Antiinflammatory preparations, non-steroids for topical use",
            "level5": "M02AA28",
            "who_name": "piketoprofen"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M02",
            "level2_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level3": "M02A",
            "level3_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level4": "M02AA",
            "level4_description": "Antiinflammatory preparations, non-steroids for topical use",
            "level5": "M02AA29",
            "who_name": "esflurbiprofen"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M02",
            "level2_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level3": "M02A",
            "level3_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level4": "M02AA",
            "level4_description": "Antiinflammatory preparations, non-steroids for topical use",
            "level5": "M02AA31",
            "who_name": "loxoprofen"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M02",
            "level2_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level3": "M02A",
            "level3_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level4": "M02AB",
            "level4_description": "Capsaicin and similar agents",
            "level5": "M02AB01",
            "who_name": "capsaicin"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M02",
            "level2_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level3": "M02A",
            "level3_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level4": "M02AB",
            "level4_description": "Capsaicin and similar agents",
            "level5": "M02AB02",
            "who_name": "zucapsaicin"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M02",
            "level2_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level3": "M02A",
            "level3_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level4": "M02AX",
            "level4_description": "Other topical products for joint and muscular pain",
            "level5": "M02AX02",
            "who_name": "tolazoline"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M02",
            "level2_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level3": "M02A",
            "level3_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level4": "M02AX",
            "level4_description": "Other topical products for joint and muscular pain",
            "level5": "M02AX03",
            "who_name": "dimethyl sulfoxide"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M02",
            "level2_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level3": "M02A",
            "level3_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level4": "M02AX",
            "level4_description": "Other topical products for joint and muscular pain",
            "level5": "M02AX05",
            "who_name": "idrocilamide"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M02",
            "level2_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level3": "M02A",
            "level3_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level4": "M02AX",
            "level4_description": "Other topical products for joint and muscular pain",
            "level5": "M02AX06",
            "who_name": "tolperisone"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M02",
            "level2_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level3": "M02A",
            "level3_description": "TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN",
            "level4": "M02AX",
            "level4_description": "Other topical products for joint and muscular pain",
            "level5": "M02AX10",
            "who_name": "various"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M03",
            "level2_description": "MUSCLE RELAXANTS",
            "level3": "M03A",
            "level3_description": "MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",
            "level4": "M03AA",
            "level4_description": "Curare alkaloids",
            "level5": "M03AA01",
            "who_name": "alcuronium"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M03",
            "level2_description": "MUSCLE RELAXANTS",
            "level3": "M03A",
            "level3_description": "MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",
            "level4": "M03AA",
            "level4_description": "Curare alkaloids",
            "level5": "M03AA02",
            "who_name": "tubocurarine"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M03",
            "level2_description": "MUSCLE RELAXANTS",
            "level3": "M03A",
            "level3_description": "MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",
            "level4": "M03AA",
            "level4_description": "Curare alkaloids",
            "level5": "M03AA04",
            "who_name": "dimethyltubocurarine"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M03",
            "level2_description": "MUSCLE RELAXANTS",
            "level3": "M03A",
            "level3_description": "MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",
            "level4": "M03AB",
            "level4_description": "Choline derivatives",
            "level5": "M03AB01",
            "who_name": "suxamethonium"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M03",
            "level2_description": "MUSCLE RELAXANTS",
            "level3": "M03A",
            "level3_description": "MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",
            "level4": "M03AC",
            "level4_description": "Other quaternary ammonium compounds",
            "level5": "M03AC01",
            "who_name": "pancuronium"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M03",
            "level2_description": "MUSCLE RELAXANTS",
            "level3": "M03A",
            "level3_description": "MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",
            "level4": "M03AC",
            "level4_description": "Other quaternary ammonium compounds",
            "level5": "M03AC02",
            "who_name": "gallamine"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M03",
            "level2_description": "MUSCLE RELAXANTS",
            "level3": "M03A",
            "level3_description": "MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",
            "level4": "M03AC",
            "level4_description": "Other quaternary ammonium compounds",
            "level5": "M03AC03",
            "who_name": "vecuronium"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M03",
            "level2_description": "MUSCLE RELAXANTS",
            "level3": "M03A",
            "level3_description": "MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",
            "level4": "M03AC",
            "level4_description": "Other quaternary ammonium compounds",
            "level5": "M03AC04",
            "who_name": "atracurium"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M03",
            "level2_description": "MUSCLE RELAXANTS",
            "level3": "M03A",
            "level3_description": "MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",
            "level4": "M03AC",
            "level4_description": "Other quaternary ammonium compounds",
            "level5": "M03AC05",
            "who_name": "hexafluronium"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M03",
            "level2_description": "MUSCLE RELAXANTS",
            "level3": "M03A",
            "level3_description": "MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",
            "level4": "M03AC",
            "level4_description": "Other quaternary ammonium compounds",
            "level5": "M03AC06",
            "who_name": "pipecuronium bromide"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M03",
            "level2_description": "MUSCLE RELAXANTS",
            "level3": "M03A",
            "level3_description": "MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",
            "level4": "M03AC",
            "level4_description": "Other quaternary ammonium compounds",
            "level5": "M03AC07",
            "who_name": "doxacurium chloride"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M03",
            "level2_description": "MUSCLE RELAXANTS",
            "level3": "M03A",
            "level3_description": "MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",
            "level4": "M03AC",
            "level4_description": "Other quaternary ammonium compounds",
            "level5": "M03AC08",
            "who_name": "fazadinium bromide"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M03",
            "level2_description": "MUSCLE RELAXANTS",
            "level3": "M03A",
            "level3_description": "MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",
            "level4": "M03AC",
            "level4_description": "Other quaternary ammonium compounds",
            "level5": "M03AC09",
            "who_name": "rocuronium bromide"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M03",
            "level2_description": "MUSCLE RELAXANTS",
            "level3": "M03A",
            "level3_description": "MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",
            "level4": "M03AC",
            "level4_description": "Other quaternary ammonium compounds",
            "level5": "M03AC10",
            "who_name": "mivacurium chloride"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M03",
            "level2_description": "MUSCLE RELAXANTS",
            "level3": "M03A",
            "level3_description": "MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",
            "level4": "M03AC",
            "level4_description": "Other quaternary ammonium compounds",
            "level5": "M03AC11",
            "who_name": "cisatracurium"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M03",
            "level2_description": "MUSCLE RELAXANTS",
            "level3": "M03A",
            "level3_description": "MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS",
            "level4": "M03AX",
            "level4_description": "Other muscle relaxants, peripherally acting agents",
            "level5": "M03AX01",
            "who_name": "botulinum toxin"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M03",
            "level2_description": "MUSCLE RELAXANTS",
            "level3": "M03B",
            "level3_description": "MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",
            "level4": "M03BA",
            "level4_description": "Carbamic acid esters",
            "level5": "M03BA01",
            "who_name": "phenprobamate"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M03",
            "level2_description": "MUSCLE RELAXANTS",
            "level3": "M03B",
            "level3_description": "MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",
            "level4": "M03BA",
            "level4_description": "Carbamic acid esters",
            "level5": "M03BA02",
            "who_name": "carisoprodol"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M03",
            "level2_description": "MUSCLE RELAXANTS",
            "level3": "M03B",
            "level3_description": "MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",
            "level4": "M03BA",
            "level4_description": "Carbamic acid esters",
            "level5": "M03BA03",
            "who_name": "methocarbamol"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M03",
            "level2_description": "MUSCLE RELAXANTS",
            "level3": "M03B",
            "level3_description": "MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",
            "level4": "M03BA",
            "level4_description": "Carbamic acid esters",
            "level5": "M03BA04",
            "who_name": "styramate"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M03",
            "level2_description": "MUSCLE RELAXANTS",
            "level3": "M03B",
            "level3_description": "MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",
            "level4": "M03BA",
            "level4_description": "Carbamic acid esters",
            "level5": "M03BA05",
            "who_name": "febarbamate"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M03",
            "level2_description": "MUSCLE RELAXANTS",
            "level3": "M03B",
            "level3_description": "MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",
            "level4": "M03BA",
            "level4_description": "Carbamic acid esters",
            "level5": "M03BA51",
            "who_name": "phenprobamate, combinations excl. psycholeptics"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M03",
            "level2_description": "MUSCLE RELAXANTS",
            "level3": "M03B",
            "level3_description": "MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",
            "level4": "M03BA",
            "level4_description": "Carbamic acid esters",
            "level5": "M03BA52",
            "who_name": "carisoprodol, combinations excl. psycholeptics"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M03",
            "level2_description": "MUSCLE RELAXANTS",
            "level3": "M03B",
            "level3_description": "MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",
            "level4": "M03BA",
            "level4_description": "Carbamic acid esters",
            "level5": "M03BA53",
            "who_name": "methocarbamol, combinations excl. psycholeptics"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M03",
            "level2_description": "MUSCLE RELAXANTS",
            "level3": "M03B",
            "level3_description": "MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",
            "level4": "M03BA",
            "level4_description": "Carbamic acid esters",
            "level5": "M03BA71",
            "who_name": "phenprobamate, combinations with psycholeptics"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M03",
            "level2_description": "MUSCLE RELAXANTS",
            "level3": "M03B",
            "level3_description": "MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",
            "level4": "M03BA",
            "level4_description": "Carbamic acid esters",
            "level5": "M03BA72",
            "who_name": "carisoprodol, combinations with psycholeptics"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M03",
            "level2_description": "MUSCLE RELAXANTS",
            "level3": "M03B",
            "level3_description": "MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",
            "level4": "M03BA",
            "level4_description": "Carbamic acid esters",
            "level5": "M03BA73",
            "who_name": "methocarbamol, combinations with psycholeptics"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M03",
            "level2_description": "MUSCLE RELAXANTS",
            "level3": "M03B",
            "level3_description": "MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",
            "level4": "M03BB",
            "level4_description": "Oxazol, thiazine, and triazine derivatives",
            "level5": "M03BB02",
            "who_name": "chlormezanone"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M03",
            "level2_description": "MUSCLE RELAXANTS",
            "level3": "M03B",
            "level3_description": "MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",
            "level4": "M03BB",
            "level4_description": "Oxazol, thiazine, and triazine derivatives",
            "level5": "M03BB03",
            "who_name": "chlorzoxazone"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M03",
            "level2_description": "MUSCLE RELAXANTS",
            "level3": "M03B",
            "level3_description": "MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",
            "level4": "M03BB",
            "level4_description": "Oxazol, thiazine, and triazine derivatives",
            "level5": "M03BB52",
            "who_name": "chlormezanone, combinations excl. psycholeptics"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M03",
            "level2_description": "MUSCLE RELAXANTS",
            "level3": "M03B",
            "level3_description": "MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",
            "level4": "M03BB",
            "level4_description": "Oxazol, thiazine, and triazine derivatives",
            "level5": "M03BB53",
            "who_name": "chlorzoxazone, combinations excl. psycholeptics"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M03",
            "level2_description": "MUSCLE RELAXANTS",
            "level3": "M03B",
            "level3_description": "MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",
            "level4": "M03BB",
            "level4_description": "Oxazol, thiazine, and triazine derivatives",
            "level5": "M03BB72",
            "who_name": "chlormezanone, combinations with psycholeptics"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M03",
            "level2_description": "MUSCLE RELAXANTS",
            "level3": "M03B",
            "level3_description": "MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",
            "level4": "M03BB",
            "level4_description": "Oxazol, thiazine, and triazine derivatives",
            "level5": "M03BB73",
            "who_name": "chlorzoxazone, combinations with psycholeptics"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M03",
            "level2_description": "MUSCLE RELAXANTS",
            "level3": "M03B",
            "level3_description": "MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",
            "level4": "M03BC",
            "level4_description": "Ethers, chemically close to antihistamines",
            "level5": "M03BC01",
            "who_name": "orphenadrine (citrate)"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M03",
            "level2_description": "MUSCLE RELAXANTS",
            "level3": "M03B",
            "level3_description": "MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",
            "level4": "M03BC",
            "level4_description": "Ethers, chemically close to antihistamines",
            "level5": "M03BC51",
            "who_name": "orphenadrine, combinations"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M03",
            "level2_description": "MUSCLE RELAXANTS",
            "level3": "M03B",
            "level3_description": "MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",
            "level4": "M03BX",
            "level4_description": "Other centrally acting agents",
            "level5": "M03BX01",
            "who_name": "baclofen"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M03",
            "level2_description": "MUSCLE RELAXANTS",
            "level3": "M03B",
            "level3_description": "MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",
            "level4": "M03BX",
            "level4_description": "Other centrally acting agents",
            "level5": "M03BX02",
            "who_name": "tizanidine"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M03",
            "level2_description": "MUSCLE RELAXANTS",
            "level3": "M03B",
            "level3_description": "MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",
            "level4": "M03BX",
            "level4_description": "Other centrally acting agents",
            "level5": "M03BX03",
            "who_name": "pridinol"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M03",
            "level2_description": "MUSCLE RELAXANTS",
            "level3": "M03B",
            "level3_description": "MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",
            "level4": "M03BX",
            "level4_description": "Other centrally acting agents",
            "level5": "M03BX04",
            "who_name": "tolperisone"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M03",
            "level2_description": "MUSCLE RELAXANTS",
            "level3": "M03B",
            "level3_description": "MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",
            "level4": "M03BX",
            "level4_description": "Other centrally acting agents",
            "level5": "M03BX05",
            "who_name": "thiocolchicoside"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M03",
            "level2_description": "MUSCLE RELAXANTS",
            "level3": "M03B",
            "level3_description": "MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",
            "level4": "M03BX",
            "level4_description": "Other centrally acting agents",
            "level5": "M03BX06",
            "who_name": "mephenesin"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M03",
            "level2_description": "MUSCLE RELAXANTS",
            "level3": "M03B",
            "level3_description": "MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",
            "level4": "M03BX",
            "level4_description": "Other centrally acting agents",
            "level5": "M03BX07",
            "who_name": "tetrazepam"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M03",
            "level2_description": "MUSCLE RELAXANTS",
            "level3": "M03B",
            "level3_description": "MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",
            "level4": "M03BX",
            "level4_description": "Other centrally acting agents",
            "level5": "M03BX08",
            "who_name": "cyclobenzaprine"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M03",
            "level2_description": "MUSCLE RELAXANTS",
            "level3": "M03B",
            "level3_description": "MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",
            "level4": "M03BX",
            "level4_description": "Other centrally acting agents",
            "level5": "M03BX09",
            "who_name": "eperisone"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M03",
            "level2_description": "MUSCLE RELAXANTS",
            "level3": "M03B",
            "level3_description": "MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",
            "level4": "M03BX",
            "level4_description": "Other centrally acting agents",
            "level5": "M03BX30",
            "who_name": "fenyramidol"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M03",
            "level2_description": "MUSCLE RELAXANTS",
            "level3": "M03B",
            "level3_description": "MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS",
            "level4": "M03BX",
            "level4_description": "Other centrally acting agents",
            "level5": "M03BX55",
            "who_name": "thiocolchicoside, combinations"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M03",
            "level2_description": "MUSCLE RELAXANTS",
            "level3": "M03C",
            "level3_description": "MUSCLE RELAXANTS, DIRECTLY ACTING AGENTS",
            "level4": "M03CA",
            "level4_description": "Dantrolene and derivatives",
            "level5": "M03CA01",
            "who_name": "dantrolene"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M04",
            "level2_description": "ANTIGOUT PREPARATIONS",
            "level3": "M04A",
            "level3_description": "ANTIGOUT PREPARATIONS",
            "level4": "M04AA",
            "level4_description": "Preparations inhibiting uric acid production",
            "level5": "M04AA01",
            "who_name": "allopurinol"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M04",
            "level2_description": "ANTIGOUT PREPARATIONS",
            "level3": "M04A",
            "level3_description": "ANTIGOUT PREPARATIONS",
            "level4": "M04AA",
            "level4_description": "Preparations inhibiting uric acid production",
            "level5": "M04AA02",
            "who_name": "tisopurine"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M04",
            "level2_description": "ANTIGOUT PREPARATIONS",
            "level3": "M04A",
            "level3_description": "ANTIGOUT PREPARATIONS",
            "level4": "M04AA",
            "level4_description": "Preparations inhibiting uric acid production",
            "level5": "M04AA03",
            "who_name": "febuxostat"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M04",
            "level2_description": "ANTIGOUT PREPARATIONS",
            "level3": "M04A",
            "level3_description": "ANTIGOUT PREPARATIONS",
            "level4": "M04AA",
            "level4_description": "Preparations inhibiting uric acid production",
            "level5": "M04AA51",
            "who_name": "allopurinol, combinations"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M04",
            "level2_description": "ANTIGOUT PREPARATIONS",
            "level3": "M04A",
            "level3_description": "ANTIGOUT PREPARATIONS",
            "level4": "M04AB",
            "level4_description": "Preparations increasing uric acid excretion",
            "level5": "M04AB01",
            "who_name": "probenecid"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M04",
            "level2_description": "ANTIGOUT PREPARATIONS",
            "level3": "M04A",
            "level3_description": "ANTIGOUT PREPARATIONS",
            "level4": "M04AB",
            "level4_description": "Preparations increasing uric acid excretion",
            "level5": "M04AB02",
            "who_name": "sulfinpyrazone"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M04",
            "level2_description": "ANTIGOUT PREPARATIONS",
            "level3": "M04A",
            "level3_description": "ANTIGOUT PREPARATIONS",
            "level4": "M04AB",
            "level4_description": "Preparations increasing uric acid excretion",
            "level5": "M04AB03",
            "who_name": "benzbromarone"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M04",
            "level2_description": "ANTIGOUT PREPARATIONS",
            "level3": "M04A",
            "level3_description": "ANTIGOUT PREPARATIONS",
            "level4": "M04AB",
            "level4_description": "Preparations increasing uric acid excretion",
            "level5": "M04AB04",
            "who_name": "isobromindione"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M04",
            "level2_description": "ANTIGOUT PREPARATIONS",
            "level3": "M04A",
            "level3_description": "ANTIGOUT PREPARATIONS",
            "level4": "M04AB",
            "level4_description": "Preparations increasing uric acid excretion",
            "level5": "M04AB05",
            "who_name": "lesinurad"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M04",
            "level2_description": "ANTIGOUT PREPARATIONS",
            "level3": "M04A",
            "level3_description": "ANTIGOUT PREPARATIONS",
            "level4": "M04AC",
            "level4_description": "Preparations with no effect on uric acid metabolism",
            "level5": "M04AC01",
            "who_name": "colchicine"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M04",
            "level2_description": "ANTIGOUT PREPARATIONS",
            "level3": "M04A",
            "level3_description": "ANTIGOUT PREPARATIONS",
            "level4": "M04AC",
            "level4_description": "Preparations with no effect on uric acid metabolism",
            "level5": "M04AC02",
            "who_name": "cinchophen"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M04",
            "level2_description": "ANTIGOUT PREPARATIONS",
            "level3": "M04A",
            "level3_description": "ANTIGOUT PREPARATIONS",
            "level4": "M04AX",
            "level4_description": "Other antigout preparations",
            "level5": "M04AX01",
            "who_name": "urate oxidase"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M04",
            "level2_description": "ANTIGOUT PREPARATIONS",
            "level3": "M04A",
            "level3_description": "ANTIGOUT PREPARATIONS",
            "level4": "M04AX",
            "level4_description": "Other antigout preparations",
            "level5": "M04AX02",
            "who_name": "pegloticase"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M05",
            "level2_description": "DRUGS FOR TREATMENT OF BONE DISEASES",
            "level3": "M05B",
            "level3_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
            "level4": "M05BA",
            "level4_description": "Bisphosphonates",
            "level5": "M05BA01",
            "who_name": "etidronic acid"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M05",
            "level2_description": "DRUGS FOR TREATMENT OF BONE DISEASES",
            "level3": "M05B",
            "level3_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
            "level4": "M05BA",
            "level4_description": "Bisphosphonates",
            "level5": "M05BA02",
            "who_name": "clodronic acid"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M05",
            "level2_description": "DRUGS FOR TREATMENT OF BONE DISEASES",
            "level3": "M05B",
            "level3_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
            "level4": "M05BA",
            "level4_description": "Bisphosphonates",
            "level5": "M05BA03",
            "who_name": "pamidronic acid"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M05",
            "level2_description": "DRUGS FOR TREATMENT OF BONE DISEASES",
            "level3": "M05B",
            "level3_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
            "level4": "M05BA",
            "level4_description": "Bisphosphonates",
            "level5": "M05BA04",
            "who_name": "alendronic acid"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M05",
            "level2_description": "DRUGS FOR TREATMENT OF BONE DISEASES",
            "level3": "M05B",
            "level3_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
            "level4": "M05BA",
            "level4_description": "Bisphosphonates",
            "level5": "M05BA05",
            "who_name": "tiludronic acid"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M05",
            "level2_description": "DRUGS FOR TREATMENT OF BONE DISEASES",
            "level3": "M05B",
            "level3_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
            "level4": "M05BA",
            "level4_description": "Bisphosphonates",
            "level5": "M05BA06",
            "who_name": "ibandronic acid"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M05",
            "level2_description": "DRUGS FOR TREATMENT OF BONE DISEASES",
            "level3": "M05B",
            "level3_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
            "level4": "M05BA",
            "level4_description": "Bisphosphonates",
            "level5": "M05BA07",
            "who_name": "risedronic acid"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M05",
            "level2_description": "DRUGS FOR TREATMENT OF BONE DISEASES",
            "level3": "M05B",
            "level3_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
            "level4": "M05BA",
            "level4_description": "Bisphosphonates",
            "level5": "M05BA08",
            "who_name": "zoledronic acid"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M05",
            "level2_description": "DRUGS FOR TREATMENT OF BONE DISEASES",
            "level3": "M05B",
            "level3_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
            "level4": "M05BB",
            "level4_description": "Bisphosphonates, combinations",
            "level5": "M05BB01",
            "who_name": "etidronic acid and calcium, sequential"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M05",
            "level2_description": "DRUGS FOR TREATMENT OF BONE DISEASES",
            "level3": "M05B",
            "level3_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
            "level4": "M05BB",
            "level4_description": "Bisphosphonates, combinations",
            "level5": "M05BB02",
            "who_name": "risedronic acid and calcium, sequential"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M05",
            "level2_description": "DRUGS FOR TREATMENT OF BONE DISEASES",
            "level3": "M05B",
            "level3_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
            "level4": "M05BB",
            "level4_description": "Bisphosphonates, combinations",
            "level5": "M05BB03",
            "who_name": "alendronic acid and colecalciferol"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M05",
            "level2_description": "DRUGS FOR TREATMENT OF BONE DISEASES",
            "level3": "M05B",
            "level3_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
            "level4": "M05BB",
            "level4_description": "Bisphosphonates, combinations",
            "level5": "M05BB04",
            "who_name": "risedronic acid, calcium and colecalciferol, sequential"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M05",
            "level2_description": "DRUGS FOR TREATMENT OF BONE DISEASES",
            "level3": "M05B",
            "level3_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
            "level4": "M05BB",
            "level4_description": "Bisphosphonates, combinations",
            "level5": "M05BB05",
            "who_name": "alendronic acid, calcium and colecalciferol, sequential"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M05",
            "level2_description": "DRUGS FOR TREATMENT OF BONE DISEASES",
            "level3": "M05B",
            "level3_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
            "level4": "M05BB",
            "level4_description": "Bisphosphonates, combinations",
            "level5": "M05BB06",
            "who_name": "alendronic acid and alfacalcidol, sequential"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M05",
            "level2_description": "DRUGS FOR TREATMENT OF BONE DISEASES",
            "level3": "M05B",
            "level3_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
            "level4": "M05BB",
            "level4_description": "Bisphosphonates, combinations",
            "level5": "M05BB07",
            "who_name": "risedronic acid and colecalciferol"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M05",
            "level2_description": "DRUGS FOR TREATMENT OF BONE DISEASES",
            "level3": "M05B",
            "level3_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
            "level4": "M05BB",
            "level4_description": "Bisphosphonates, combinations",
            "level5": "M05BB08",
            "who_name": "zoledronic acid, calcium and colecalciferol, sequential"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M05",
            "level2_description": "DRUGS FOR TREATMENT OF BONE DISEASES",
            "level3": "M05B",
            "level3_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
            "level4": "M05BB",
            "level4_description": "Bisphosphonates, combinations",
            "level5": "M05BB09",
            "who_name": "ibandronic acid and colecalciferol"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M05",
            "level2_description": "DRUGS FOR TREATMENT OF BONE DISEASES",
            "level3": "M05B",
            "level3_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
            "level4": "M05BC",
            "level4_description": "Bone morphogenetic proteins",
            "level5": "M05BC01",
            "who_name": "dibotermin alfa"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M05",
            "level2_description": "DRUGS FOR TREATMENT OF BONE DISEASES",
            "level3": "M05B",
            "level3_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
            "level4": "M05BC",
            "level4_description": "Bone morphogenetic proteins",
            "level5": "M05BC02",
            "who_name": "eptotermin alfa"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M05",
            "level2_description": "DRUGS FOR TREATMENT OF BONE DISEASES",
            "level3": "M05B",
            "level3_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
            "level4": "M05BX",
            "level4_description": "Other drugs affecting bone structure and mineralization",
            "level5": "M05BX01",
            "who_name": "ipriflavone"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M05",
            "level2_description": "DRUGS FOR TREATMENT OF BONE DISEASES",
            "level3": "M05B",
            "level3_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
            "level4": "M05BX",
            "level4_description": "Other drugs affecting bone structure and mineralization",
            "level5": "M05BX02",
            "who_name": "aluminium chlorohydrate"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M05",
            "level2_description": "DRUGS FOR TREATMENT OF BONE DISEASES",
            "level3": "M05B",
            "level3_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
            "level4": "M05BX",
            "level4_description": "Other drugs affecting bone structure and mineralization",
            "level5": "M05BX03",
            "who_name": "strontium ranelate"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M05",
            "level2_description": "DRUGS FOR TREATMENT OF BONE DISEASES",
            "level3": "M05B",
            "level3_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
            "level4": "M05BX",
            "level4_description": "Other drugs affecting bone structure and mineralization",
            "level5": "M05BX04",
            "who_name": "denosumab"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M05",
            "level2_description": "DRUGS FOR TREATMENT OF BONE DISEASES",
            "level3": "M05B",
            "level3_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
            "level4": "M05BX",
            "level4_description": "Other drugs affecting bone structure and mineralization",
            "level5": "M05BX05",
            "who_name": "burosumab"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M05",
            "level2_description": "DRUGS FOR TREATMENT OF BONE DISEASES",
            "level3": "M05B",
            "level3_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
            "level4": "M05BX",
            "level4_description": "Other drugs affecting bone structure and mineralization",
            "level5": "M05BX06",
            "who_name": "romosozumab"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M05",
            "level2_description": "DRUGS FOR TREATMENT OF BONE DISEASES",
            "level3": "M05B",
            "level3_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
            "level4": "M05BX",
            "level4_description": "Other drugs affecting bone structure and mineralization",
            "level5": "M05BX07",
            "who_name": "vosoritide"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M05",
            "level2_description": "DRUGS FOR TREATMENT OF BONE DISEASES",
            "level3": "M05B",
            "level3_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
            "level4": "M05BX",
            "level4_description": "Other drugs affecting bone structure and mineralization",
            "level5": "M05BX53",
            "who_name": "strontium ranelate and colecalciferol"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M09",
            "level2_description": "OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM",
            "level3": "M09A",
            "level3_description": "OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM",
            "level4": "M09AA",
            "level4_description": "Quinine and derivatives",
            "level5": "M09AA01",
            "who_name": "hydroquinine"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M09",
            "level2_description": "OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM",
            "level3": "M09A",
            "level3_description": "OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM",
            "level4": "M09AA",
            "level4_description": "Quinine and derivatives",
            "level5": "M09AA72",
            "who_name": "quinine, combinations with psycholeptics"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M09",
            "level2_description": "OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM",
            "level3": "M09A",
            "level3_description": "OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM",
            "level4": "M09AB",
            "level4_description": "Enzymes",
            "level5": "M09AB01",
            "who_name": "chymopapain"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M09",
            "level2_description": "OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM",
            "level3": "M09A",
            "level3_description": "OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM",
            "level4": "M09AB",
            "level4_description": "Enzymes",
            "level5": "M09AB02",
            "who_name": "collagenase clostridium histolyticum"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M09",
            "level2_description": "OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM",
            "level3": "M09A",
            "level3_description": "OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM",
            "level4": "M09AB",
            "level4_description": "Enzymes",
            "level5": "M09AB03",
            "who_name": "bromelains"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M09",
            "level2_description": "OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM",
            "level3": "M09A",
            "level3_description": "OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM",
            "level4": "M09AB",
            "level4_description": "Enzymes",
            "level5": "M09AB52",
            "who_name": "trypsin, combinations"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M09",
            "level2_description": "OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM",
            "level3": "M09A",
            "level3_description": "OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM",
            "level4": "M09AX",
            "level4_description": "Other drugs for disorders of the musculo-skeletal system",
            "level5": "M09AX01",
            "who_name": "hyaluronic acid"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M09",
            "level2_description": "OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM",
            "level3": "M09A",
            "level3_description": "OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM",
            "level4": "M09AX",
            "level4_description": "Other drugs for disorders of the musculo-skeletal system",
            "level5": "M09AX02",
            "who_name": "chondrocytes, autologous"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M09",
            "level2_description": "OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM",
            "level3": "M09A",
            "level3_description": "OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM",
            "level4": "M09AX",
            "level4_description": "Other drugs for disorders of the musculo-skeletal system",
            "level5": "M09AX03",
            "who_name": "ataluren"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M09",
            "level2_description": "OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM",
            "level3": "M09A",
            "level3_description": "OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM",
            "level4": "M09AX",
            "level4_description": "Other drugs for disorders of the musculo-skeletal system",
            "level5": "M09AX04",
            "who_name": "drisapersen"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M09",
            "level2_description": "OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM",
            "level3": "M09A",
            "level3_description": "OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM",
            "level4": "M09AX",
            "level4_description": "Other drugs for disorders of the musculo-skeletal system",
            "level5": "M09AX05",
            "who_name": "aceneuramic acid"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M09",
            "level2_description": "OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM",
            "level3": "M09A",
            "level3_description": "OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM",
            "level4": "M09AX",
            "level4_description": "Other drugs for disorders of the musculo-skeletal system",
            "level5": "M09AX06",
            "who_name": "eteplirsen"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M09",
            "level2_description": "OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM",
            "level3": "M09A",
            "level3_description": "OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM",
            "level4": "M09AX",
            "level4_description": "Other drugs for disorders of the musculo-skeletal system",
            "level5": "M09AX07",
            "who_name": "nusinersen"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M09",
            "level2_description": "OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM",
            "level3": "M09A",
            "level3_description": "OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM",
            "level4": "M09AX",
            "level4_description": "Other drugs for disorders of the musculo-skeletal system",
            "level5": "M09AX08",
            "who_name": "golodirsen"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M09",
            "level2_description": "OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM",
            "level3": "M09A",
            "level3_description": "OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM",
            "level4": "M09AX",
            "level4_description": "Other drugs for disorders of the musculo-skeletal system",
            "level5": "M09AX09",
            "who_name": "onasemnogene abeparvovec"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M09",
            "level2_description": "OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM",
            "level3": "M09A",
            "level3_description": "OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM",
            "level4": "M09AX",
            "level4_description": "Other drugs for disorders of the musculo-skeletal system",
            "level5": "M09AX10",
            "who_name": "risdiplam"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M09",
            "level2_description": "OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM",
            "level3": "M09A",
            "level3_description": "OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM",
            "level4": "M09AX",
            "level4_description": "Other drugs for disorders of the musculo-skeletal system",
            "level5": "M09AX11",
            "who_name": "palovarotene"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M09",
            "level2_description": "OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM",
            "level3": "M09A",
            "level3_description": "OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM",
            "level4": "M09AX",
            "level4_description": "Other drugs for disorders of the musculo-skeletal system",
            "level5": "M09AX12",
            "who_name": "viltolarsen"
        },
        {
            "level1": "M",
            "level1_description": "MUSCULO-SKELETAL SYSTEM",
            "level2": "M09",
            "level2_description": "OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM",
            "level3": "M09A",
            "level3_description": "OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM",
            "level4": "M09AX",
            "level4_description": "Other drugs for disorders of the musculo-skeletal system",
            "level5": "M09AX13",
            "who_name": "casimersen"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01A",
            "level3_description": "ANESTHETICS, GENERAL",
            "level4": "N01AA",
            "level4_description": "Ethers",
            "level5": "N01AA01",
            "who_name": "diethyl ether"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01A",
            "level3_description": "ANESTHETICS, GENERAL",
            "level4": "N01AA",
            "level4_description": "Ethers",
            "level5": "N01AA02",
            "who_name": "vinyl ether"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01A",
            "level3_description": "ANESTHETICS, GENERAL",
            "level4": "N01AB",
            "level4_description": "Halogenated hydrocarbons",
            "level5": "N01AB01",
            "who_name": "halothane"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01A",
            "level3_description": "ANESTHETICS, GENERAL",
            "level4": "N01AB",
            "level4_description": "Halogenated hydrocarbons",
            "level5": "N01AB02",
            "who_name": "chloroform"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01A",
            "level3_description": "ANESTHETICS, GENERAL",
            "level4": "N01AB",
            "level4_description": "Halogenated hydrocarbons",
            "level5": "N01AB04",
            "who_name": "enflurane"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01A",
            "level3_description": "ANESTHETICS, GENERAL",
            "level4": "N01AB",
            "level4_description": "Halogenated hydrocarbons",
            "level5": "N01AB05",
            "who_name": "trichloroethylene"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01A",
            "level3_description": "ANESTHETICS, GENERAL",
            "level4": "N01AB",
            "level4_description": "Halogenated hydrocarbons",
            "level5": "N01AB06",
            "who_name": "isoflurane"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01A",
            "level3_description": "ANESTHETICS, GENERAL",
            "level4": "N01AB",
            "level4_description": "Halogenated hydrocarbons",
            "level5": "N01AB07",
            "who_name": "desflurane"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01A",
            "level3_description": "ANESTHETICS, GENERAL",
            "level4": "N01AB",
            "level4_description": "Halogenated hydrocarbons",
            "level5": "N01AB08",
            "who_name": "sevoflurane"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01A",
            "level3_description": "ANESTHETICS, GENERAL",
            "level4": "N01AF",
            "level4_description": "Barbiturates, plain",
            "level5": "N01AF01",
            "who_name": "methohexital"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01A",
            "level3_description": "ANESTHETICS, GENERAL",
            "level4": "N01AF",
            "level4_description": "Barbiturates, plain",
            "level5": "N01AF02",
            "who_name": "hexobarbital"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01A",
            "level3_description": "ANESTHETICS, GENERAL",
            "level4": "N01AF",
            "level4_description": "Barbiturates, plain",
            "level5": "N01AF03",
            "who_name": "thiopental"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01A",
            "level3_description": "ANESTHETICS, GENERAL",
            "level4": "N01AG",
            "level4_description": "Barbiturates in combination with other drugs",
            "level5": "N01AG01",
            "who_name": "narcobarbital"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01A",
            "level3_description": "ANESTHETICS, GENERAL",
            "level4": "N01AH",
            "level4_description": "Opioid anesthetics",
            "level5": "N01AH01",
            "who_name": "fentanyl"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01A",
            "level3_description": "ANESTHETICS, GENERAL",
            "level4": "N01AH",
            "level4_description": "Opioid anesthetics",
            "level5": "N01AH02",
            "who_name": "alfentanil"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01A",
            "level3_description": "ANESTHETICS, GENERAL",
            "level4": "N01AH",
            "level4_description": "Opioid anesthetics",
            "level5": "N01AH03",
            "who_name": "sufentanil"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01A",
            "level3_description": "ANESTHETICS, GENERAL",
            "level4": "N01AH",
            "level4_description": "Opioid anesthetics",
            "level5": "N01AH04",
            "who_name": "phenoperidine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01A",
            "level3_description": "ANESTHETICS, GENERAL",
            "level4": "N01AH",
            "level4_description": "Opioid anesthetics",
            "level5": "N01AH05",
            "who_name": "anileridine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01A",
            "level3_description": "ANESTHETICS, GENERAL",
            "level4": "N01AH",
            "level4_description": "Opioid anesthetics",
            "level5": "N01AH06",
            "who_name": "remifentanil"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01A",
            "level3_description": "ANESTHETICS, GENERAL",
            "level4": "N01AH",
            "level4_description": "Opioid anesthetics",
            "level5": "N01AH51",
            "who_name": "fentanyl, combinations"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01A",
            "level3_description": "ANESTHETICS, GENERAL",
            "level4": "N01AX",
            "level4_description": "Other general anesthetics",
            "level5": "N01AX03",
            "who_name": "ketamine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01A",
            "level3_description": "ANESTHETICS, GENERAL",
            "level4": "N01AX",
            "level4_description": "Other general anesthetics",
            "level5": "N01AX04",
            "who_name": "propanidid"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01A",
            "level3_description": "ANESTHETICS, GENERAL",
            "level4": "N01AX",
            "level4_description": "Other general anesthetics",
            "level5": "N01AX05",
            "who_name": "alfaxalone"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01A",
            "level3_description": "ANESTHETICS, GENERAL",
            "level4": "N01AX",
            "level4_description": "Other general anesthetics",
            "level5": "N01AX07",
            "who_name": "etomidate"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01A",
            "level3_description": "ANESTHETICS, GENERAL",
            "level4": "N01AX",
            "level4_description": "Other general anesthetics",
            "level5": "N01AX10",
            "who_name": "propofol"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01A",
            "level3_description": "ANESTHETICS, GENERAL",
            "level4": "N01AX",
            "level4_description": "Other general anesthetics",
            "level5": "N01AX11",
            "who_name": "sodium oxybate"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01A",
            "level3_description": "ANESTHETICS, GENERAL",
            "level4": "N01AX",
            "level4_description": "Other general anesthetics",
            "level5": "N01AX13",
            "who_name": "nitrous oxide"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01A",
            "level3_description": "ANESTHETICS, GENERAL",
            "level4": "N01AX",
            "level4_description": "Other general anesthetics",
            "level5": "N01AX14",
            "who_name": "esketamine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01A",
            "level3_description": "ANESTHETICS, GENERAL",
            "level4": "N01AX",
            "level4_description": "Other general anesthetics",
            "level5": "N01AX15",
            "who_name": "xenon"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01A",
            "level3_description": "ANESTHETICS, GENERAL",
            "level4": "N01AX",
            "level4_description": "Other general anesthetics",
            "level5": "N01AX63",
            "who_name": "nitrous oxide, combinations"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01B",
            "level3_description": "ANESTHETICS, LOCAL",
            "level4": "N01BA",
            "level4_description": "Esters of aminobenzoic acid",
            "level5": "N01BA01",
            "who_name": "metabutethamine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01B",
            "level3_description": "ANESTHETICS, LOCAL",
            "level4": "N01BA",
            "level4_description": "Esters of aminobenzoic acid",
            "level5": "N01BA02",
            "who_name": "procaine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01B",
            "level3_description": "ANESTHETICS, LOCAL",
            "level4": "N01BA",
            "level4_description": "Esters of aminobenzoic acid",
            "level5": "N01BA03",
            "who_name": "tetracaine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01B",
            "level3_description": "ANESTHETICS, LOCAL",
            "level4": "N01BA",
            "level4_description": "Esters of aminobenzoic acid",
            "level5": "N01BA04",
            "who_name": "chloroprocaine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01B",
            "level3_description": "ANESTHETICS, LOCAL",
            "level4": "N01BA",
            "level4_description": "Esters of aminobenzoic acid",
            "level5": "N01BA05",
            "who_name": "benzocaine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01B",
            "level3_description": "ANESTHETICS, LOCAL",
            "level4": "N01BA",
            "level4_description": "Esters of aminobenzoic acid",
            "level5": "N01BA52",
            "who_name": "procaine, combinations"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01B",
            "level3_description": "ANESTHETICS, LOCAL",
            "level4": "N01BA",
            "level4_description": "Esters of aminobenzoic acid",
            "level5": "N01BA53",
            "who_name": "tetracaine, combinations"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01B",
            "level3_description": "ANESTHETICS, LOCAL",
            "level4": "N01BB",
            "level4_description": "Amides",
            "level5": "N01BB01",
            "who_name": "bupivacaine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01B",
            "level3_description": "ANESTHETICS, LOCAL",
            "level4": "N01BB",
            "level4_description": "Amides",
            "level5": "N01BB02",
            "who_name": "lidocaine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01B",
            "level3_description": "ANESTHETICS, LOCAL",
            "level4": "N01BB",
            "level4_description": "Amides",
            "level5": "N01BB03",
            "who_name": "mepivacaine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01B",
            "level3_description": "ANESTHETICS, LOCAL",
            "level4": "N01BB",
            "level4_description": "Amides",
            "level5": "N01BB04",
            "who_name": "prilocaine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01B",
            "level3_description": "ANESTHETICS, LOCAL",
            "level4": "N01BB",
            "level4_description": "Amides",
            "level5": "N01BB05",
            "who_name": "butanilicaine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01B",
            "level3_description": "ANESTHETICS, LOCAL",
            "level4": "N01BB",
            "level4_description": "Amides",
            "level5": "N01BB06",
            "who_name": "cinchocaine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01B",
            "level3_description": "ANESTHETICS, LOCAL",
            "level4": "N01BB",
            "level4_description": "Amides",
            "level5": "N01BB07",
            "who_name": "etidocaine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01B",
            "level3_description": "ANESTHETICS, LOCAL",
            "level4": "N01BB",
            "level4_description": "Amides",
            "level5": "N01BB08",
            "who_name": "articaine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01B",
            "level3_description": "ANESTHETICS, LOCAL",
            "level4": "N01BB",
            "level4_description": "Amides",
            "level5": "N01BB09",
            "who_name": "ropivacaine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01B",
            "level3_description": "ANESTHETICS, LOCAL",
            "level4": "N01BB",
            "level4_description": "Amides",
            "level5": "N01BB10",
            "who_name": "levobupivacaine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01B",
            "level3_description": "ANESTHETICS, LOCAL",
            "level4": "N01BB",
            "level4_description": "Amides",
            "level5": "N01BB20",
            "who_name": "combinations"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01B",
            "level3_description": "ANESTHETICS, LOCAL",
            "level4": "N01BB",
            "level4_description": "Amides",
            "level5": "N01BB51",
            "who_name": "bupivacaine, combinations"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01B",
            "level3_description": "ANESTHETICS, LOCAL",
            "level4": "N01BB",
            "level4_description": "Amides",
            "level5": "N01BB52",
            "who_name": "lidocaine, combinations"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01B",
            "level3_description": "ANESTHETICS, LOCAL",
            "level4": "N01BB",
            "level4_description": "Amides",
            "level5": "N01BB53",
            "who_name": "mepivacaine, combinations"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01B",
            "level3_description": "ANESTHETICS, LOCAL",
            "level4": "N01BB",
            "level4_description": "Amides",
            "level5": "N01BB54",
            "who_name": "prilocaine, combinations"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01B",
            "level3_description": "ANESTHETICS, LOCAL",
            "level4": "N01BB",
            "level4_description": "Amides",
            "level5": "N01BB57",
            "who_name": "etidocaine, combinations"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01B",
            "level3_description": "ANESTHETICS, LOCAL",
            "level4": "N01BB",
            "level4_description": "Amides",
            "level5": "N01BB58",
            "who_name": "articaine, combinations"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01B",
            "level3_description": "ANESTHETICS, LOCAL",
            "level4": "N01BB",
            "level4_description": "Amides",
            "level5": "N01BB59",
            "who_name": "bupivacaine and meloxicam"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01B",
            "level3_description": "ANESTHETICS, LOCAL",
            "level4": "N01BC",
            "level4_description": "Esters of benzoic acid",
            "level5": "N01BC01",
            "who_name": "cocaine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01B",
            "level3_description": "ANESTHETICS, LOCAL",
            "level4": "N01BX",
            "level4_description": "Other local anesthetics",
            "level5": "N01BX01",
            "who_name": "ethyl chloride"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01B",
            "level3_description": "ANESTHETICS, LOCAL",
            "level4": "N01BX",
            "level4_description": "Other local anesthetics",
            "level5": "N01BX02",
            "who_name": "dyclonine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01B",
            "level3_description": "ANESTHETICS, LOCAL",
            "level4": "N01BX",
            "level4_description": "Other local anesthetics",
            "level5": "N01BX03",
            "who_name": "phenol"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N01",
            "level2_description": "ANESTHETICS",
            "level3": "N01B",
            "level3_description": "ANESTHETICS, LOCAL",
            "level4": "N01BX",
            "level4_description": "Other local anesthetics",
            "level5": "N01BX04",
            "who_name": "capsaicin"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AA",
            "level4_description": "Natural opium alkaloids",
            "level5": "N02AA01",
            "who_name": "morphine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AA",
            "level4_description": "Natural opium alkaloids",
            "level5": "N02AA02",
            "who_name": "opium"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AA",
            "level4_description": "Natural opium alkaloids",
            "level5": "N02AA03",
            "who_name": "hydromorphone"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AA",
            "level4_description": "Natural opium alkaloids",
            "level5": "N02AA04",
            "who_name": "nicomorphine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AA",
            "level4_description": "Natural opium alkaloids",
            "level5": "N02AA05",
            "who_name": "oxycodone"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AA",
            "level4_description": "Natural opium alkaloids",
            "level5": "N02AA08",
            "who_name": "dihydrocodeine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AA",
            "level4_description": "Natural opium alkaloids",
            "level5": "N02AA10",
            "who_name": "papaveretum"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AA",
            "level4_description": "Natural opium alkaloids",
            "level5": "N02AA11",
            "who_name": "oxymorphone"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AA",
            "level4_description": "Natural opium alkaloids",
            "level5": "N02AA51",
            "who_name": "morphine, combinations"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AA",
            "level4_description": "Natural opium alkaloids",
            "level5": "N02AA53",
            "who_name": "hydromorphone and naloxone"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AA",
            "level4_description": "Natural opium alkaloids",
            "level5": "N02AA55",
            "who_name": "oxycodone and naloxone"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AA",
            "level4_description": "Natural opium alkaloids",
            "level5": "N02AA56",
            "who_name": "oxycodone and naltrexone"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AA",
            "level4_description": "Natural opium alkaloids",
            "level5": "N02AA58",
            "who_name": "dihydrocodeine, combinations"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AA",
            "level4_description": "Natural opium alkaloids",
            "level5": "N02AA59",
            "who_name": "codeine, combinations excl. psycholeptics"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AA",
            "level4_description": "Natural opium alkaloids",
            "level5": "N02AA79",
            "who_name": "codeine, combinations with psycholeptics"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AB",
            "level4_description": "Phenylpiperidine derivatives",
            "level5": "N02AB01",
            "who_name": "ketobemidone"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AB",
            "level4_description": "Phenylpiperidine derivatives",
            "level5": "N02AB02",
            "who_name": "pethidine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AB",
            "level4_description": "Phenylpiperidine derivatives",
            "level5": "N02AB03",
            "who_name": "fentanyl"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AB",
            "level4_description": "Phenylpiperidine derivatives",
            "level5": "N02AB52",
            "who_name": "pethidine, combinations excl. psycholeptics"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AB",
            "level4_description": "Phenylpiperidine derivatives",
            "level5": "N02AB72",
            "who_name": "pethidine, combinations with psycholeptics"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AC",
            "level4_description": "Diphenylpropylamine derivatives",
            "level5": "N02AC01",
            "who_name": "dextromoramide"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AC",
            "level4_description": "Diphenylpropylamine derivatives",
            "level5": "N02AC03",
            "who_name": "piritramide"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AC",
            "level4_description": "Diphenylpropylamine derivatives",
            "level5": "N02AC04",
            "who_name": "dextropropoxyphene"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AC",
            "level4_description": "Diphenylpropylamine derivatives",
            "level5": "N02AC05",
            "who_name": "bezitramide"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AC",
            "level4_description": "Diphenylpropylamine derivatives",
            "level5": "N02AC52",
            "who_name": "methadone, combinations excl. psycholeptics"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AC",
            "level4_description": "Diphenylpropylamine derivatives",
            "level5": "N02AC54",
            "who_name": "dextropropoxyphene, combinations excl. psycholeptics"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AC",
            "level4_description": "Diphenylpropylamine derivatives",
            "level5": "N02AC74",
            "who_name": "dextropropoxyphene, combinations with psycholeptics"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AD",
            "level4_description": "Benzomorphan derivatives",
            "level5": "N02AD01",
            "who_name": "pentazocine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AD",
            "level4_description": "Benzomorphan derivatives",
            "level5": "N02AD02",
            "who_name": "phenazocine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AE",
            "level4_description": "Oripavine derivatives",
            "level5": "N02AE01",
            "who_name": "buprenorphine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AF",
            "level4_description": "Morphinan derivatives",
            "level5": "N02AF01",
            "who_name": "butorphanol"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AF",
            "level4_description": "Morphinan derivatives",
            "level5": "N02AF02",
            "who_name": "nalbuphine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AG",
            "level4_description": "Opioids in combination with antispasmodics",
            "level5": "N02AG01",
            "who_name": "morphine and antispasmodics"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AG",
            "level4_description": "Opioids in combination with antispasmodics",
            "level5": "N02AG02",
            "who_name": "ketobemidone and antispasmodics"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AG",
            "level4_description": "Opioids in combination with antispasmodics",
            "level5": "N02AG03",
            "who_name": "pethidine and antispasmodics"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AG",
            "level4_description": "Opioids in combination with antispasmodics",
            "level5": "N02AG04",
            "who_name": "hydromorphone and antispasmodics"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AJ",
            "level4_description": "Opioids in combination with non-opioid analgesics",
            "level5": "N02AJ01",
            "who_name": "dihydrocodeine and paracetamol"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AJ",
            "level4_description": "Opioids in combination with non-opioid analgesics",
            "level5": "N02AJ02",
            "who_name": "dihydrocodeine and acetylsalicylic acid"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AJ",
            "level4_description": "Opioids in combination with non-opioid analgesics",
            "level5": "N02AJ03",
            "who_name": "dihydrocodeine and other non-opioid analgesics"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AJ",
            "level4_description": "Opioids in combination with non-opioid analgesics",
            "level5": "N02AJ06",
            "who_name": "codeine and paracetamol"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AJ",
            "level4_description": "Opioids in combination with non-opioid analgesics",
            "level5": "N02AJ07",
            "who_name": "codeine and acetylsalicylic acid"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AJ",
            "level4_description": "Opioids in combination with non-opioid analgesics",
            "level5": "N02AJ08",
            "who_name": "codeine and ibuprofen"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AJ",
            "level4_description": "Opioids in combination with non-opioid analgesics",
            "level5": "N02AJ09",
            "who_name": "codeine and other non-opioid analgesics"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AJ",
            "level4_description": "Opioids in combination with non-opioid analgesics",
            "level5": "N02AJ13",
            "who_name": "tramadol and paracetamol"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AJ",
            "level4_description": "Opioids in combination with non-opioid analgesics",
            "level5": "N02AJ14",
            "who_name": "tramadol and dexketoprofen"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AJ",
            "level4_description": "Opioids in combination with non-opioid analgesics",
            "level5": "N02AJ15",
            "who_name": "tramadol and other non-opioid analgesics"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AJ",
            "level4_description": "Opioids in combination with non-opioid analgesics",
            "level5": "N02AJ16",
            "who_name": "tramadol and celecoxib"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AJ",
            "level4_description": "Opioids in combination with non-opioid analgesics",
            "level5": "N02AJ17",
            "who_name": "oxycodone and paracetamol"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AJ",
            "level4_description": "Opioids in combination with non-opioid analgesics",
            "level5": "N02AJ18",
            "who_name": "oxycodone and acetylsalicylic acid"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AJ",
            "level4_description": "Opioids in combination with non-opioid analgesics",
            "level5": "N02AJ19",
            "who_name": "oxycodone and ibuprofen"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AX",
            "level4_description": "Other opioids",
            "level5": "N02AX01",
            "who_name": "tilidine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AX",
            "level4_description": "Other opioids",
            "level5": "N02AX02",
            "who_name": "tramadol"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AX",
            "level4_description": "Other opioids",
            "level5": "N02AX03",
            "who_name": "dezocine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AX",
            "level4_description": "Other opioids",
            "level5": "N02AX05",
            "who_name": "meptazinol"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AX",
            "level4_description": "Other opioids",
            "level5": "N02AX06",
            "who_name": "tapentadol"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AX",
            "level4_description": "Other opioids",
            "level5": "N02AX07",
            "who_name": "oliceridine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02A",
            "level3_description": "OPIOIDS",
            "level4": "N02AX",
            "level4_description": "Other opioids",
            "level5": "N02AX51",
            "who_name": "tilidine and naloxone"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BA",
            "level4_description": "Salicylic acid and derivatives",
            "level5": "N02BA01",
            "who_name": "acetylsalicylic acid"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BA",
            "level4_description": "Salicylic acid and derivatives",
            "level5": "N02BA02",
            "who_name": "aloxiprin"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BA",
            "level4_description": "Salicylic acid and derivatives",
            "level5": "N02BA03",
            "who_name": "choline salicylate"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BA",
            "level4_description": "Salicylic acid and derivatives",
            "level5": "N02BA04",
            "who_name": "sodium salicylate"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BA",
            "level4_description": "Salicylic acid and derivatives",
            "level5": "N02BA05",
            "who_name": "salicylamide"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BA",
            "level4_description": "Salicylic acid and derivatives",
            "level5": "N02BA06",
            "who_name": "salsalate"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BA",
            "level4_description": "Salicylic acid and derivatives",
            "level5": "N02BA07",
            "who_name": "ethenzamide"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BA",
            "level4_description": "Salicylic acid and derivatives",
            "level5": "N02BA08",
            "who_name": "morpholine salicylate"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BA",
            "level4_description": "Salicylic acid and derivatives",
            "level5": "N02BA09",
            "who_name": "dipyrocetyl"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BA",
            "level4_description": "Salicylic acid and derivatives",
            "level5": "N02BA10",
            "who_name": "benorilate"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BA",
            "level4_description": "Salicylic acid and derivatives",
            "level5": "N02BA11",
            "who_name": "diflunisal"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BA",
            "level4_description": "Salicylic acid and derivatives",
            "level5": "N02BA12",
            "who_name": "potassium salicylate"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BA",
            "level4_description": "Salicylic acid and derivatives",
            "level5": "N02BA14",
            "who_name": "guacetisal"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BA",
            "level4_description": "Salicylic acid and derivatives",
            "level5": "N02BA15",
            "who_name": "carbasalate calcium"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BA",
            "level4_description": "Salicylic acid and derivatives",
            "level5": "N02BA16",
            "who_name": "imidazole salicylate"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BA",
            "level4_description": "Salicylic acid and derivatives",
            "level5": "N02BA51",
            "who_name": "acetylsalicylic acid, combinations excl. psycholeptics"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BA",
            "level4_description": "Salicylic acid and derivatives",
            "level5": "N02BA55",
            "who_name": "salicylamide, combinations excl. psycholeptics"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BA",
            "level4_description": "Salicylic acid and derivatives",
            "level5": "N02BA57",
            "who_name": "ethenzamide, combinations excl. psycholeptics"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BA",
            "level4_description": "Salicylic acid and derivatives",
            "level5": "N02BA59",
            "who_name": "dipyrocetyl, combinations excl. psycholeptics"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BA",
            "level4_description": "Salicylic acid and derivatives",
            "level5": "N02BA65",
            "who_name": "carbasalate calcium combinations excl. psycholeptics"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BA",
            "level4_description": "Salicylic acid and derivatives",
            "level5": "N02BA71",
            "who_name": "acetylsalicylic acid, combinations with psycholeptics"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BA",
            "level4_description": "Salicylic acid and derivatives",
            "level5": "N02BA75",
            "who_name": "salicylamide, combinations with psycholeptics"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BA",
            "level4_description": "Salicylic acid and derivatives",
            "level5": "N02BA77",
            "who_name": "ethenzamide, combinations with psycholeptics"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BA",
            "level4_description": "Salicylic acid and derivatives",
            "level5": "N02BA79",
            "who_name": "dipyrocetyl, combinations with psycholeptics"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BB",
            "level4_description": "Pyrazolones",
            "level5": "N02BB01",
            "who_name": "phenazone"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BB",
            "level4_description": "Pyrazolones",
            "level5": "N02BB02",
            "who_name": "metamizole sodium"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BB",
            "level4_description": "Pyrazolones",
            "level5": "N02BB03",
            "who_name": "aminophenazone"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BB",
            "level4_description": "Pyrazolones",
            "level5": "N02BB04",
            "who_name": "propyphenazone"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BB",
            "level4_description": "Pyrazolones",
            "level5": "N02BB05",
            "who_name": "nifenazone"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BB",
            "level4_description": "Pyrazolones",
            "level5": "N02BB51",
            "who_name": "phenazone, combinations excl. psycholeptics"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BB",
            "level4_description": "Pyrazolones",
            "level5": "N02BB52",
            "who_name": "metamizole sodium, combinations excl. psycholeptics"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BB",
            "level4_description": "Pyrazolones",
            "level5": "N02BB53",
            "who_name": "aminophenazone, combinations excl. psycholeptics"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BB",
            "level4_description": "Pyrazolones",
            "level5": "N02BB54",
            "who_name": "propyphenazone, combinations excl. psycholeptics"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BB",
            "level4_description": "Pyrazolones",
            "level5": "N02BB71",
            "who_name": "phenazone, combinations with psycholeptics"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BB",
            "level4_description": "Pyrazolones",
            "level5": "N02BB72",
            "who_name": "metamizole sodium, combinations with psycholeptics"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BB",
            "level4_description": "Pyrazolones",
            "level5": "N02BB73",
            "who_name": "aminophenazone, combinations with psycholeptics"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BB",
            "level4_description": "Pyrazolones",
            "level5": "N02BB74",
            "who_name": "propyphenazone, combinations with psycholeptics"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BE",
            "level4_description": "Anilides",
            "level5": "N02BE01",
            "who_name": "paracetamol"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BE",
            "level4_description": "Anilides",
            "level5": "N02BE03",
            "who_name": "phenacetin"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BE",
            "level4_description": "Anilides",
            "level5": "N02BE04",
            "who_name": "bucetin"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BE",
            "level4_description": "Anilides",
            "level5": "N02BE05",
            "who_name": "propacetamol"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BE",
            "level4_description": "Anilides",
            "level5": "N02BE51",
            "who_name": "paracetamol, combinations excl. psycholeptics"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BE",
            "level4_description": "Anilides",
            "level5": "N02BE53",
            "who_name": "phenacetin, combinations excl. psycholeptics"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BE",
            "level4_description": "Anilides",
            "level5": "N02BE54",
            "who_name": "bucetin, combinations excl. psycholeptics"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BE",
            "level4_description": "Anilides",
            "level5": "N02BE71",
            "who_name": "paracetamol, combinations with psycholeptics"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BE",
            "level4_description": "Anilides",
            "level5": "N02BE73",
            "who_name": "phenacetin, combinations with psycholeptics"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BE",
            "level4_description": "Anilides",
            "level5": "N02BE74",
            "who_name": "bucetin, combinations with psycholeptics"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BG",
            "level4_description": "Other analgesics and antipyretics",
            "level5": "N02BG02",
            "who_name": "rimazolium"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BG",
            "level4_description": "Other analgesics and antipyretics",
            "level5": "N02BG03",
            "who_name": "glafenine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BG",
            "level4_description": "Other analgesics and antipyretics",
            "level5": "N02BG04",
            "who_name": "floctafenine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BG",
            "level4_description": "Other analgesics and antipyretics",
            "level5": "N02BG05",
            "who_name": "viminol"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BG",
            "level4_description": "Other analgesics and antipyretics",
            "level5": "N02BG06",
            "who_name": "nefopam"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BG",
            "level4_description": "Other analgesics and antipyretics",
            "level5": "N02BG07",
            "who_name": "flupirtine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BG",
            "level4_description": "Other analgesics and antipyretics",
            "level5": "N02BG08",
            "who_name": "ziconotide"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BG",
            "level4_description": "Other analgesics and antipyretics",
            "level5": "N02BG09",
            "who_name": "methoxyflurane"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BG",
            "level4_description": "Other analgesics and antipyretics",
            "level5": "N02BG10",
            "who_name": "cannabinoids"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BG",
            "level4_description": "Other analgesics and antipyretics",
            "level5": "N02BG11",
            "who_name": "mirogabalin"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02B",
            "level3_description": "OTHER ANALGESICS AND ANTIPYRETICS",
            "level4": "N02BG",
            "level4_description": "Other analgesics and antipyretics",
            "level5": "N02BG12",
            "who_name": "tanezumab"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02C",
            "level3_description": "ANTIMIGRAINE PREPARATIONS",
            "level4": "N02CA",
            "level4_description": "Ergot alkaloids",
            "level5": "N02CA01",
            "who_name": "dihydroergotamine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02C",
            "level3_description": "ANTIMIGRAINE PREPARATIONS",
            "level4": "N02CA",
            "level4_description": "Ergot alkaloids",
            "level5": "N02CA02",
            "who_name": "ergotamine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02C",
            "level3_description": "ANTIMIGRAINE PREPARATIONS",
            "level4": "N02CA",
            "level4_description": "Ergot alkaloids",
            "level5": "N02CA04",
            "who_name": "methysergide"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02C",
            "level3_description": "ANTIMIGRAINE PREPARATIONS",
            "level4": "N02CA",
            "level4_description": "Ergot alkaloids",
            "level5": "N02CA07",
            "who_name": "lisuride"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02C",
            "level3_description": "ANTIMIGRAINE PREPARATIONS",
            "level4": "N02CA",
            "level4_description": "Ergot alkaloids",
            "level5": "N02CA51",
            "who_name": "dihydroergotamine, combinations"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02C",
            "level3_description": "ANTIMIGRAINE PREPARATIONS",
            "level4": "N02CA",
            "level4_description": "Ergot alkaloids",
            "level5": "N02CA52",
            "who_name": "ergotamine, combinations excl. psycholeptics"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02C",
            "level3_description": "ANTIMIGRAINE PREPARATIONS",
            "level4": "N02CA",
            "level4_description": "Ergot alkaloids",
            "level5": "N02CA72",
            "who_name": "ergotamine, combinations with psycholeptics"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02C",
            "level3_description": "ANTIMIGRAINE PREPARATIONS",
            "level4": "N02CB",
            "level4_description": "Corticosteroid derivatives",
            "level5": "N02CB01",
            "who_name": "flumedroxone"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02C",
            "level3_description": "ANTIMIGRAINE PREPARATIONS",
            "level4": "N02CC",
            "level4_description": "Selective serotonin (5HT1) agonists",
            "level5": "N02CC01",
            "who_name": "sumatriptan"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02C",
            "level3_description": "ANTIMIGRAINE PREPARATIONS",
            "level4": "N02CC",
            "level4_description": "Selective serotonin (5HT1) agonists",
            "level5": "N02CC02",
            "who_name": "naratriptan"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02C",
            "level3_description": "ANTIMIGRAINE PREPARATIONS",
            "level4": "N02CC",
            "level4_description": "Selective serotonin (5HT1) agonists",
            "level5": "N02CC03",
            "who_name": "zolmitriptan"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02C",
            "level3_description": "ANTIMIGRAINE PREPARATIONS",
            "level4": "N02CC",
            "level4_description": "Selective serotonin (5HT1) agonists",
            "level5": "N02CC04",
            "who_name": "rizatriptan"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02C",
            "level3_description": "ANTIMIGRAINE PREPARATIONS",
            "level4": "N02CC",
            "level4_description": "Selective serotonin (5HT1) agonists",
            "level5": "N02CC05",
            "who_name": "almotriptan"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02C",
            "level3_description": "ANTIMIGRAINE PREPARATIONS",
            "level4": "N02CC",
            "level4_description": "Selective serotonin (5HT1) agonists",
            "level5": "N02CC06",
            "who_name": "eletriptan"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02C",
            "level3_description": "ANTIMIGRAINE PREPARATIONS",
            "level4": "N02CC",
            "level4_description": "Selective serotonin (5HT1) agonists",
            "level5": "N02CC07",
            "who_name": "frovatriptan"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02C",
            "level3_description": "ANTIMIGRAINE PREPARATIONS",
            "level4": "N02CC",
            "level4_description": "Selective serotonin (5HT1) agonists",
            "level5": "N02CC08",
            "who_name": "lasmiditan"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02C",
            "level3_description": "ANTIMIGRAINE PREPARATIONS",
            "level4": "N02CD",
            "level4_description": "Calcitonin gene-related peptide (CGRP) antagonists",
            "level5": "N02CD01",
            "who_name": "erenumab"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02C",
            "level3_description": "ANTIMIGRAINE PREPARATIONS",
            "level4": "N02CD",
            "level4_description": "Calcitonin gene-related peptide (CGRP) antagonists",
            "level5": "N02CD02",
            "who_name": "galcanezumab"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02C",
            "level3_description": "ANTIMIGRAINE PREPARATIONS",
            "level4": "N02CD",
            "level4_description": "Calcitonin gene-related peptide (CGRP) antagonists",
            "level5": "N02CD03",
            "who_name": "fremanezumab"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02C",
            "level3_description": "ANTIMIGRAINE PREPARATIONS",
            "level4": "N02CD",
            "level4_description": "Calcitonin gene-related peptide (CGRP) antagonists",
            "level5": "N02CD04",
            "who_name": "ubrogepant"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02C",
            "level3_description": "ANTIMIGRAINE PREPARATIONS",
            "level4": "N02CD",
            "level4_description": "Calcitonin gene-related peptide (CGRP) antagonists",
            "level5": "N02CD05",
            "who_name": "eptinezumab"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02C",
            "level3_description": "ANTIMIGRAINE PREPARATIONS",
            "level4": "N02CD",
            "level4_description": "Calcitonin gene-related peptide (CGRP) antagonists",
            "level5": "N02CD06",
            "who_name": "rimegepant"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02C",
            "level3_description": "ANTIMIGRAINE PREPARATIONS",
            "level4": "N02CD",
            "level4_description": "Calcitonin gene-related peptide (CGRP) antagonists",
            "level5": "N02CD07",
            "who_name": "atogepant"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02C",
            "level3_description": "ANTIMIGRAINE PREPARATIONS",
            "level4": "N02CX",
            "level4_description": "Other antimigraine preparations",
            "level5": "N02CX01",
            "who_name": "pizotifen"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02C",
            "level3_description": "ANTIMIGRAINE PREPARATIONS",
            "level4": "N02CX",
            "level4_description": "Other antimigraine preparations",
            "level5": "N02CX02",
            "who_name": "clonidine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02C",
            "level3_description": "ANTIMIGRAINE PREPARATIONS",
            "level4": "N02CX",
            "level4_description": "Other antimigraine preparations",
            "level5": "N02CX03",
            "who_name": "iprazochrome"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02C",
            "level3_description": "ANTIMIGRAINE PREPARATIONS",
            "level4": "N02CX",
            "level4_description": "Other antimigraine preparations",
            "level5": "N02CX05",
            "who_name": "dimetotiazine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N02",
            "level2_description": "ANALGESICS",
            "level3": "N02C",
            "level3_description": "ANTIMIGRAINE PREPARATIONS",
            "level4": "N02CX",
            "level4_description": "Other antimigraine preparations",
            "level5": "N02CX06",
            "who_name": "oxetorone"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AA",
            "level4_description": "Barbiturates and derivatives",
            "level5": "N03AA01",
            "who_name": "methylphenobarbital"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AA",
            "level4_description": "Barbiturates and derivatives",
            "level5": "N03AA02",
            "who_name": "phenobarbital"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AA",
            "level4_description": "Barbiturates and derivatives",
            "level5": "N03AA03",
            "who_name": "primidone"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AA",
            "level4_description": "Barbiturates and derivatives",
            "level5": "N03AA04",
            "who_name": "barbexaclone"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AA",
            "level4_description": "Barbiturates and derivatives",
            "level5": "N03AA30",
            "who_name": "metharbital"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AB",
            "level4_description": "Hydantoin derivatives",
            "level5": "N03AB01",
            "who_name": "ethotoin"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AB",
            "level4_description": "Hydantoin derivatives",
            "level5": "N03AB02",
            "who_name": "phenytoin"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AB",
            "level4_description": "Hydantoin derivatives",
            "level5": "N03AB03",
            "who_name": "amino(diphenylhydantoin) valeric acid"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AB",
            "level4_description": "Hydantoin derivatives",
            "level5": "N03AB04",
            "who_name": "mephenytoin"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AB",
            "level4_description": "Hydantoin derivatives",
            "level5": "N03AB05",
            "who_name": "fosphenytoin"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AB",
            "level4_description": "Hydantoin derivatives",
            "level5": "N03AB52",
            "who_name": "phenytoin, combinations"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AB",
            "level4_description": "Hydantoin derivatives",
            "level5": "N03AB54",
            "who_name": "mephenytoin, combinations"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AC",
            "level4_description": "Oxazolidine derivatives",
            "level5": "N03AC01",
            "who_name": "paramethadione"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AC",
            "level4_description": "Oxazolidine derivatives",
            "level5": "N03AC02",
            "who_name": "trimethadione"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AC",
            "level4_description": "Oxazolidine derivatives",
            "level5": "N03AC03",
            "who_name": "ethadione"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AD",
            "level4_description": "Succinimide derivatives",
            "level5": "N03AD01",
            "who_name": "ethosuximide"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AD",
            "level4_description": "Succinimide derivatives",
            "level5": "N03AD02",
            "who_name": "phensuximide"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AD",
            "level4_description": "Succinimide derivatives",
            "level5": "N03AD03",
            "who_name": "mesuximide"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AD",
            "level4_description": "Succinimide derivatives",
            "level5": "N03AD51",
            "who_name": "ethosuximide, combinations"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AE",
            "level4_description": "Benzodiazepine derivatives",
            "level5": "N03AE01",
            "who_name": "clonazepam"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AF",
            "level4_description": "Carboxamide derivatives",
            "level5": "N03AF01",
            "who_name": "carbamazepine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AF",
            "level4_description": "Carboxamide derivatives",
            "level5": "N03AF02",
            "who_name": "oxcarbazepine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AF",
            "level4_description": "Carboxamide derivatives",
            "level5": "N03AF03",
            "who_name": "rufinamide"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AF",
            "level4_description": "Carboxamide derivatives",
            "level5": "N03AF04",
            "who_name": "eslicarbazepine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AG",
            "level4_description": "Fatty acid derivatives",
            "level5": "N03AG01",
            "who_name": "valproic acid"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AG",
            "level4_description": "Fatty acid derivatives",
            "level5": "N03AG02",
            "who_name": "valpromide"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AG",
            "level4_description": "Fatty acid derivatives",
            "level5": "N03AG03",
            "who_name": "aminobutyric acid"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AG",
            "level4_description": "Fatty acid derivatives",
            "level5": "N03AG04",
            "who_name": "vigabatrin"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AG",
            "level4_description": "Fatty acid derivatives",
            "level5": "N03AG05",
            "who_name": "progabide"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AG",
            "level4_description": "Fatty acid derivatives",
            "level5": "N03AG06",
            "who_name": "tiagabine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AX",
            "level4_description": "Other antiepileptics",
            "level5": "N03AX03",
            "who_name": "sultiame"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AX",
            "level4_description": "Other antiepileptics",
            "level5": "N03AX07",
            "who_name": "phenacemide"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AX",
            "level4_description": "Other antiepileptics",
            "level5": "N03AX09",
            "who_name": "lamotrigine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AX",
            "level4_description": "Other antiepileptics",
            "level5": "N03AX10",
            "who_name": "felbamate"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AX",
            "level4_description": "Other antiepileptics",
            "level5": "N03AX11",
            "who_name": "topiramate"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AX",
            "level4_description": "Other antiepileptics",
            "level5": "N03AX12",
            "who_name": "gabapentin"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AX",
            "level4_description": "Other antiepileptics",
            "level5": "N03AX13",
            "who_name": "pheneturide"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AX",
            "level4_description": "Other antiepileptics",
            "level5": "N03AX14",
            "who_name": "levetiracetam"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AX",
            "level4_description": "Other antiepileptics",
            "level5": "N03AX15",
            "who_name": "zonisamide"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AX",
            "level4_description": "Other antiepileptics",
            "level5": "N03AX16",
            "who_name": "pregabalin"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AX",
            "level4_description": "Other antiepileptics",
            "level5": "N03AX17",
            "who_name": "stiripentol"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AX",
            "level4_description": "Other antiepileptics",
            "level5": "N03AX18",
            "who_name": "lacosamide"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AX",
            "level4_description": "Other antiepileptics",
            "level5": "N03AX19",
            "who_name": "carisbamate"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AX",
            "level4_description": "Other antiepileptics",
            "level5": "N03AX21",
            "who_name": "retigabine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AX",
            "level4_description": "Other antiepileptics",
            "level5": "N03AX22",
            "who_name": "perampanel"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AX",
            "level4_description": "Other antiepileptics",
            "level5": "N03AX23",
            "who_name": "brivaracetam"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AX",
            "level4_description": "Other antiepileptics",
            "level5": "N03AX24",
            "who_name": "cannabidiol"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AX",
            "level4_description": "Other antiepileptics",
            "level5": "N03AX25",
            "who_name": "cenobamate"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AX",
            "level4_description": "Other antiepileptics",
            "level5": "N03AX26",
            "who_name": "fenfluramine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AX",
            "level4_description": "Other antiepileptics",
            "level5": "N03AX27",
            "who_name": "ganaxolone"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N03",
            "level2_description": "ANTIEPILEPTICS",
            "level3": "N03A",
            "level3_description": "ANTIEPILEPTICS",
            "level4": "N03AX",
            "level4_description": "Other antiepileptics",
            "level5": "N03AX30",
            "who_name": "beclamide"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N04",
            "level2_description": "ANTI-PARKINSON DRUGS",
            "level3": "N04A",
            "level3_description": "ANTICHOLINERGIC AGENTS",
            "level4": "N04AA",
            "level4_description": "Tertiary amines",
            "level5": "N04AA01",
            "who_name": "trihexyphenidyl"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N04",
            "level2_description": "ANTI-PARKINSON DRUGS",
            "level3": "N04A",
            "level3_description": "ANTICHOLINERGIC AGENTS",
            "level4": "N04AA",
            "level4_description": "Tertiary amines",
            "level5": "N04AA02",
            "who_name": "biperiden"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N04",
            "level2_description": "ANTI-PARKINSON DRUGS",
            "level3": "N04A",
            "level3_description": "ANTICHOLINERGIC AGENTS",
            "level4": "N04AA",
            "level4_description": "Tertiary amines",
            "level5": "N04AA03",
            "who_name": "metixene"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N04",
            "level2_description": "ANTI-PARKINSON DRUGS",
            "level3": "N04A",
            "level3_description": "ANTICHOLINERGIC AGENTS",
            "level4": "N04AA",
            "level4_description": "Tertiary amines",
            "level5": "N04AA04",
            "who_name": "procyclidine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N04",
            "level2_description": "ANTI-PARKINSON DRUGS",
            "level3": "N04A",
            "level3_description": "ANTICHOLINERGIC AGENTS",
            "level4": "N04AA",
            "level4_description": "Tertiary amines",
            "level5": "N04AA05",
            "who_name": "profenamine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N04",
            "level2_description": "ANTI-PARKINSON DRUGS",
            "level3": "N04A",
            "level3_description": "ANTICHOLINERGIC AGENTS",
            "level4": "N04AA",
            "level4_description": "Tertiary amines",
            "level5": "N04AA08",
            "who_name": "dexetimide"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N04",
            "level2_description": "ANTI-PARKINSON DRUGS",
            "level3": "N04A",
            "level3_description": "ANTICHOLINERGIC AGENTS",
            "level4": "N04AA",
            "level4_description": "Tertiary amines",
            "level5": "N04AA09",
            "who_name": "phenglutarimide"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N04",
            "level2_description": "ANTI-PARKINSON DRUGS",
            "level3": "N04A",
            "level3_description": "ANTICHOLINERGIC AGENTS",
            "level4": "N04AA",
            "level4_description": "Tertiary amines",
            "level5": "N04AA10",
            "who_name": "mazaticol"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N04",
            "level2_description": "ANTI-PARKINSON DRUGS",
            "level3": "N04A",
            "level3_description": "ANTICHOLINERGIC AGENTS",
            "level4": "N04AA",
            "level4_description": "Tertiary amines",
            "level5": "N04AA11",
            "who_name": "bornaprine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N04",
            "level2_description": "ANTI-PARKINSON DRUGS",
            "level3": "N04A",
            "level3_description": "ANTICHOLINERGIC AGENTS",
            "level4": "N04AA",
            "level4_description": "Tertiary amines",
            "level5": "N04AA12",
            "who_name": "tropatepine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N04",
            "level2_description": "ANTI-PARKINSON DRUGS",
            "level3": "N04A",
            "level3_description": "ANTICHOLINERGIC AGENTS",
            "level4": "N04AB",
            "level4_description": "Ethers chemically close to antihistamines",
            "level5": "N04AB01",
            "who_name": "etanautine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N04",
            "level2_description": "ANTI-PARKINSON DRUGS",
            "level3": "N04A",
            "level3_description": "ANTICHOLINERGIC AGENTS",
            "level4": "N04AB",
            "level4_description": "Ethers chemically close to antihistamines",
            "level5": "N04AB02",
            "who_name": "orphenadrine (chloride)"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N04",
            "level2_description": "ANTI-PARKINSON DRUGS",
            "level3": "N04A",
            "level3_description": "ANTICHOLINERGIC AGENTS",
            "level4": "N04AC",
            "level4_description": "Ethers of tropine or tropine derivatives",
            "level5": "N04AC01",
            "who_name": "benzatropine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N04",
            "level2_description": "ANTI-PARKINSON DRUGS",
            "level3": "N04A",
            "level3_description": "ANTICHOLINERGIC AGENTS",
            "level4": "N04AC",
            "level4_description": "Ethers of tropine or tropine derivatives",
            "level5": "N04AC30",
            "who_name": "etybenzatropine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N04",
            "level2_description": "ANTI-PARKINSON DRUGS",
            "level3": "N04B",
            "level3_description": "DOPAMINERGIC AGENTS",
            "level4": "N04BA",
            "level4_description": "Dopa and dopa derivatives",
            "level5": "N04BA01",
            "who_name": "levodopa"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N04",
            "level2_description": "ANTI-PARKINSON DRUGS",
            "level3": "N04B",
            "level3_description": "DOPAMINERGIC AGENTS",
            "level4": "N04BA",
            "level4_description": "Dopa and dopa derivatives",
            "level5": "N04BA02",
            "who_name": "levodopa and decarboxylase inhibitor"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N04",
            "level2_description": "ANTI-PARKINSON DRUGS",
            "level3": "N04B",
            "level3_description": "DOPAMINERGIC AGENTS",
            "level4": "N04BA",
            "level4_description": "Dopa and dopa derivatives",
            "level5": "N04BA03",
            "who_name": "levodopa, decarboxylase inhibitor and COMT inhibitor"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N04",
            "level2_description": "ANTI-PARKINSON DRUGS",
            "level3": "N04B",
            "level3_description": "DOPAMINERGIC AGENTS",
            "level4": "N04BA",
            "level4_description": "Dopa and dopa derivatives",
            "level5": "N04BA04",
            "who_name": "melevodopa"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N04",
            "level2_description": "ANTI-PARKINSON DRUGS",
            "level3": "N04B",
            "level3_description": "DOPAMINERGIC AGENTS",
            "level4": "N04BA",
            "level4_description": "Dopa and dopa derivatives",
            "level5": "N04BA05",
            "who_name": "melevodopa and decarboxylase inhibitor"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N04",
            "level2_description": "ANTI-PARKINSON DRUGS",
            "level3": "N04B",
            "level3_description": "DOPAMINERGIC AGENTS",
            "level4": "N04BA",
            "level4_description": "Dopa and dopa derivatives",
            "level5": "N04BA06",
            "who_name": "etilevodopa and decarboxylase inhibitor"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N04",
            "level2_description": "ANTI-PARKINSON DRUGS",
            "level3": "N04B",
            "level3_description": "DOPAMINERGIC AGENTS",
            "level4": "N04BB",
            "level4_description": "Adamantane derivatives",
            "level5": "N04BB01",
            "who_name": "amantadine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N04",
            "level2_description": "ANTI-PARKINSON DRUGS",
            "level3": "N04B",
            "level3_description": "DOPAMINERGIC AGENTS",
            "level4": "N04BC",
            "level4_description": "Dopamine agonists",
            "level5": "N04BC01",
            "who_name": "bromocriptine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N04",
            "level2_description": "ANTI-PARKINSON DRUGS",
            "level3": "N04B",
            "level3_description": "DOPAMINERGIC AGENTS",
            "level4": "N04BC",
            "level4_description": "Dopamine agonists",
            "level5": "N04BC02",
            "who_name": "pergolide"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N04",
            "level2_description": "ANTI-PARKINSON DRUGS",
            "level3": "N04B",
            "level3_description": "DOPAMINERGIC AGENTS",
            "level4": "N04BC",
            "level4_description": "Dopamine agonists",
            "level5": "N04BC03",
            "who_name": "dihydroergocryptine mesylate"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N04",
            "level2_description": "ANTI-PARKINSON DRUGS",
            "level3": "N04B",
            "level3_description": "DOPAMINERGIC AGENTS",
            "level4": "N04BC",
            "level4_description": "Dopamine agonists",
            "level5": "N04BC04",
            "who_name": "ropinirole"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N04",
            "level2_description": "ANTI-PARKINSON DRUGS",
            "level3": "N04B",
            "level3_description": "DOPAMINERGIC AGENTS",
            "level4": "N04BC",
            "level4_description": "Dopamine agonists",
            "level5": "N04BC05",
            "who_name": "pramipexole"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N04",
            "level2_description": "ANTI-PARKINSON DRUGS",
            "level3": "N04B",
            "level3_description": "DOPAMINERGIC AGENTS",
            "level4": "N04BC",
            "level4_description": "Dopamine agonists",
            "level5": "N04BC06",
            "who_name": "cabergoline"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N04",
            "level2_description": "ANTI-PARKINSON DRUGS",
            "level3": "N04B",
            "level3_description": "DOPAMINERGIC AGENTS",
            "level4": "N04BC",
            "level4_description": "Dopamine agonists",
            "level5": "N04BC07",
            "who_name": "apomorphine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N04",
            "level2_description": "ANTI-PARKINSON DRUGS",
            "level3": "N04B",
            "level3_description": "DOPAMINERGIC AGENTS",
            "level4": "N04BC",
            "level4_description": "Dopamine agonists",
            "level5": "N04BC08",
            "who_name": "piribedil"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N04",
            "level2_description": "ANTI-PARKINSON DRUGS",
            "level3": "N04B",
            "level3_description": "DOPAMINERGIC AGENTS",
            "level4": "N04BC",
            "level4_description": "Dopamine agonists",
            "level5": "N04BC09",
            "who_name": "rotigotine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N04",
            "level2_description": "ANTI-PARKINSON DRUGS",
            "level3": "N04B",
            "level3_description": "DOPAMINERGIC AGENTS",
            "level4": "N04BD",
            "level4_description": "Monoamine oxidase B inhibitors",
            "level5": "N04BD01",
            "who_name": "selegiline"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N04",
            "level2_description": "ANTI-PARKINSON DRUGS",
            "level3": "N04B",
            "level3_description": "DOPAMINERGIC AGENTS",
            "level4": "N04BD",
            "level4_description": "Monoamine oxidase B inhibitors",
            "level5": "N04BD02",
            "who_name": "rasagiline"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N04",
            "level2_description": "ANTI-PARKINSON DRUGS",
            "level3": "N04B",
            "level3_description": "DOPAMINERGIC AGENTS",
            "level4": "N04BD",
            "level4_description": "Monoamine oxidase B inhibitors",
            "level5": "N04BD03",
            "who_name": "safinamide"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N04",
            "level2_description": "ANTI-PARKINSON DRUGS",
            "level3": "N04B",
            "level3_description": "DOPAMINERGIC AGENTS",
            "level4": "N04BX",
            "level4_description": "Other dopaminergic agents",
            "level5": "N04BX01",
            "who_name": "tolcapone"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N04",
            "level2_description": "ANTI-PARKINSON DRUGS",
            "level3": "N04B",
            "level3_description": "DOPAMINERGIC AGENTS",
            "level4": "N04BX",
            "level4_description": "Other dopaminergic agents",
            "level5": "N04BX02",
            "who_name": "entacapone"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N04",
            "level2_description": "ANTI-PARKINSON DRUGS",
            "level3": "N04B",
            "level3_description": "DOPAMINERGIC AGENTS",
            "level4": "N04BX",
            "level4_description": "Other dopaminergic agents",
            "level5": "N04BX03",
            "who_name": "budipine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N04",
            "level2_description": "ANTI-PARKINSON DRUGS",
            "level3": "N04B",
            "level3_description": "DOPAMINERGIC AGENTS",
            "level4": "N04BX",
            "level4_description": "Other dopaminergic agents",
            "level5": "N04BX04",
            "who_name": "opicapone"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N04",
            "level2_description": "ANTI-PARKINSON DRUGS",
            "level3": "N04C",
            "level3_description": "OTHER ANTIPARKINSON DRUGS",
            "level4": "N04CX",
            "level4_description": "Other antiparkinson drugs",
            "level5": "N04CX01",
            "who_name": "istradefylline"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AA",
            "level4_description": "Phenothiazines with aliphatic side-chain",
            "level5": "N05AA01",
            "who_name": "chlorpromazine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AA",
            "level4_description": "Phenothiazines with aliphatic side-chain",
            "level5": "N05AA02",
            "who_name": "levomepromazine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AA",
            "level4_description": "Phenothiazines with aliphatic side-chain",
            "level5": "N05AA03",
            "who_name": "promazine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AA",
            "level4_description": "Phenothiazines with aliphatic side-chain",
            "level5": "N05AA04",
            "who_name": "acepromazine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AA",
            "level4_description": "Phenothiazines with aliphatic side-chain",
            "level5": "N05AA05",
            "who_name": "triflupromazine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AA",
            "level4_description": "Phenothiazines with aliphatic side-chain",
            "level5": "N05AA06",
            "who_name": "cyamemazine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AA",
            "level4_description": "Phenothiazines with aliphatic side-chain",
            "level5": "N05AA07",
            "who_name": "chlorproethazine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AB",
            "level4_description": "Phenothiazines with piperazine structure",
            "level5": "N05AB01",
            "who_name": "dixyrazine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AB",
            "level4_description": "Phenothiazines with piperazine structure",
            "level5": "N05AB02",
            "who_name": "fluphenazine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AB",
            "level4_description": "Phenothiazines with piperazine structure",
            "level5": "N05AB03",
            "who_name": "perphenazine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AB",
            "level4_description": "Phenothiazines with piperazine structure",
            "level5": "N05AB04",
            "who_name": "prochlorperazine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AB",
            "level4_description": "Phenothiazines with piperazine structure",
            "level5": "N05AB05",
            "who_name": "thiopropazate"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AB",
            "level4_description": "Phenothiazines with piperazine structure",
            "level5": "N05AB06",
            "who_name": "trifluoperazine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AB",
            "level4_description": "Phenothiazines with piperazine structure",
            "level5": "N05AB07",
            "who_name": "acetophenazine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AB",
            "level4_description": "Phenothiazines with piperazine structure",
            "level5": "N05AB08",
            "who_name": "thioproperazine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AB",
            "level4_description": "Phenothiazines with piperazine structure",
            "level5": "N05AB09",
            "who_name": "butaperazine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AB",
            "level4_description": "Phenothiazines with piperazine structure",
            "level5": "N05AB10",
            "who_name": "perazine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AC",
            "level4_description": "Phenothiazines with piperidine structure",
            "level5": "N05AC01",
            "who_name": "periciazine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AC",
            "level4_description": "Phenothiazines with piperidine structure",
            "level5": "N05AC02",
            "who_name": "thioridazine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AC",
            "level4_description": "Phenothiazines with piperidine structure",
            "level5": "N05AC03",
            "who_name": "mesoridazine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AC",
            "level4_description": "Phenothiazines with piperidine structure",
            "level5": "N05AC04",
            "who_name": "pipotiazine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AD",
            "level4_description": "Butyrophenone derivatives",
            "level5": "N05AD01",
            "who_name": "haloperidol"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AD",
            "level4_description": "Butyrophenone derivatives",
            "level5": "N05AD02",
            "who_name": "trifluperidol"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AD",
            "level4_description": "Butyrophenone derivatives",
            "level5": "N05AD03",
            "who_name": "melperone"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AD",
            "level4_description": "Butyrophenone derivatives",
            "level5": "N05AD04",
            "who_name": "moperone"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AD",
            "level4_description": "Butyrophenone derivatives",
            "level5": "N05AD05",
            "who_name": "pipamperone"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AD",
            "level4_description": "Butyrophenone derivatives",
            "level5": "N05AD06",
            "who_name": "bromperidol"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AD",
            "level4_description": "Butyrophenone derivatives",
            "level5": "N05AD07",
            "who_name": "benperidol"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AD",
            "level4_description": "Butyrophenone derivatives",
            "level5": "N05AD08",
            "who_name": "droperidol"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AD",
            "level4_description": "Butyrophenone derivatives",
            "level5": "N05AD09",
            "who_name": "fluanisone"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AD",
            "level4_description": "Butyrophenone derivatives",
            "level5": "N05AD10",
            "who_name": "lumateperone"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AE",
            "level4_description": "Indole derivatives",
            "level5": "N05AE01",
            "who_name": "oxypertine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AE",
            "level4_description": "Indole derivatives",
            "level5": "N05AE02",
            "who_name": "molindone"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AE",
            "level4_description": "Indole derivatives",
            "level5": "N05AE03",
            "who_name": "sertindole"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AE",
            "level4_description": "Indole derivatives",
            "level5": "N05AE04",
            "who_name": "ziprasidone"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AE",
            "level4_description": "Indole derivatives",
            "level5": "N05AE05",
            "who_name": "lurasidone"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AF",
            "level4_description": "Thioxanthene derivatives",
            "level5": "N05AF01",
            "who_name": "flupentixol"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AF",
            "level4_description": "Thioxanthene derivatives",
            "level5": "N05AF02",
            "who_name": "clopenthixol"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AF",
            "level4_description": "Thioxanthene derivatives",
            "level5": "N05AF03",
            "who_name": "chlorprothixene"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AF",
            "level4_description": "Thioxanthene derivatives",
            "level5": "N05AF04",
            "who_name": "tiotixene"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AF",
            "level4_description": "Thioxanthene derivatives",
            "level5": "N05AF05",
            "who_name": "zuclopenthixol"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AG",
            "level4_description": "Diphenylbutylpiperidine derivatives",
            "level5": "N05AG01",
            "who_name": "fluspirilene"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AG",
            "level4_description": "Diphenylbutylpiperidine derivatives",
            "level5": "N05AG02",
            "who_name": "pimozide"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AG",
            "level4_description": "Diphenylbutylpiperidine derivatives",
            "level5": "N05AG03",
            "who_name": "penfluridol"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AH",
            "level4_description": "Diazepines, oxazepines, thiazepines and oxepines",
            "level5": "N05AH01",
            "who_name": "loxapine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AH",
            "level4_description": "Diazepines, oxazepines, thiazepines and oxepines",
            "level5": "N05AH02",
            "who_name": "clozapine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AH",
            "level4_description": "Diazepines, oxazepines, thiazepines and oxepines",
            "level5": "N05AH03",
            "who_name": "olanzapine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AH",
            "level4_description": "Diazepines, oxazepines, thiazepines and oxepines",
            "level5": "N05AH04",
            "who_name": "quetiapine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AH",
            "level4_description": "Diazepines, oxazepines, thiazepines and oxepines",
            "level5": "N05AH05",
            "who_name": "asenapine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AH",
            "level4_description": "Diazepines, oxazepines, thiazepines and oxepines",
            "level5": "N05AH06",
            "who_name": "clotiapine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AL",
            "level4_description": "Benzamides",
            "level5": "N05AL01",
            "who_name": "sulpiride"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AL",
            "level4_description": "Benzamides",
            "level5": "N05AL02",
            "who_name": "sultopride"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AL",
            "level4_description": "Benzamides",
            "level5": "N05AL03",
            "who_name": "tiapride"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AL",
            "level4_description": "Benzamides",
            "level5": "N05AL04",
            "who_name": "remoxipride"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AL",
            "level4_description": "Benzamides",
            "level5": "N05AL05",
            "who_name": "amisulpride"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AL",
            "level4_description": "Benzamides",
            "level5": "N05AL06",
            "who_name": "veralipride"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AL",
            "level4_description": "Benzamides",
            "level5": "N05AL07",
            "who_name": "levosulpiride"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AN",
            "level4_description": "Lithium",
            "level5": "N05AN01",
            "who_name": "lithium"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AX",
            "level4_description": "Other antipsychotics",
            "level5": "N05AX07",
            "who_name": "prothipendyl"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AX",
            "level4_description": "Other antipsychotics",
            "level5": "N05AX08",
            "who_name": "risperidone"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AX",
            "level4_description": "Other antipsychotics",
            "level5": "N05AX10",
            "who_name": "mosapramine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AX",
            "level4_description": "Other antipsychotics",
            "level5": "N05AX11",
            "who_name": "zotepine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AX",
            "level4_description": "Other antipsychotics",
            "level5": "N05AX12",
            "who_name": "aripiprazole"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AX",
            "level4_description": "Other antipsychotics",
            "level5": "N05AX13",
            "who_name": "paliperidone"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AX",
            "level4_description": "Other antipsychotics",
            "level5": "N05AX14",
            "who_name": "iloperidone"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AX",
            "level4_description": "Other antipsychotics",
            "level5": "N05AX15",
            "who_name": "cariprazine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AX",
            "level4_description": "Other antipsychotics",
            "level5": "N05AX16",
            "who_name": "brexpiprazole"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05A",
            "level3_description": "ANTIPSYCHOTICS",
            "level4": "N05AX",
            "level4_description": "Other antipsychotics",
            "level5": "N05AX17",
            "who_name": "pimavanserin"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05B",
            "level3_description": "ANXIOLYTICS",
            "level4": "N05BA",
            "level4_description": "Benzodiazepine derivatives",
            "level5": "N05BA01",
            "who_name": "diazepam"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05B",
            "level3_description": "ANXIOLYTICS",
            "level4": "N05BA",
            "level4_description": "Benzodiazepine derivatives",
            "level5": "N05BA02",
            "who_name": "chlordiazepoxide"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05B",
            "level3_description": "ANXIOLYTICS",
            "level4": "N05BA",
            "level4_description": "Benzodiazepine derivatives",
            "level5": "N05BA03",
            "who_name": "medazepam"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05B",
            "level3_description": "ANXIOLYTICS",
            "level4": "N05BA",
            "level4_description": "Benzodiazepine derivatives",
            "level5": "N05BA04",
            "who_name": "oxazepam"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05B",
            "level3_description": "ANXIOLYTICS",
            "level4": "N05BA",
            "level4_description": "Benzodiazepine derivatives",
            "level5": "N05BA05",
            "who_name": "potassium clorazepate"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05B",
            "level3_description": "ANXIOLYTICS",
            "level4": "N05BA",
            "level4_description": "Benzodiazepine derivatives",
            "level5": "N05BA06",
            "who_name": "lorazepam"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05B",
            "level3_description": "ANXIOLYTICS",
            "level4": "N05BA",
            "level4_description": "Benzodiazepine derivatives",
            "level5": "N05BA07",
            "who_name": "adinazolam"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05B",
            "level3_description": "ANXIOLYTICS",
            "level4": "N05BA",
            "level4_description": "Benzodiazepine derivatives",
            "level5": "N05BA08",
            "who_name": "bromazepam"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05B",
            "level3_description": "ANXIOLYTICS",
            "level4": "N05BA",
            "level4_description": "Benzodiazepine derivatives",
            "level5": "N05BA09",
            "who_name": "clobazam"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05B",
            "level3_description": "ANXIOLYTICS",
            "level4": "N05BA",
            "level4_description": "Benzodiazepine derivatives",
            "level5": "N05BA10",
            "who_name": "ketazolam"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05B",
            "level3_description": "ANXIOLYTICS",
            "level4": "N05BA",
            "level4_description": "Benzodiazepine derivatives",
            "level5": "N05BA11",
            "who_name": "prazepam"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05B",
            "level3_description": "ANXIOLYTICS",
            "level4": "N05BA",
            "level4_description": "Benzodiazepine derivatives",
            "level5": "N05BA12",
            "who_name": "alprazolam"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05B",
            "level3_description": "ANXIOLYTICS",
            "level4": "N05BA",
            "level4_description": "Benzodiazepine derivatives",
            "level5": "N05BA13",
            "who_name": "halazepam"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05B",
            "level3_description": "ANXIOLYTICS",
            "level4": "N05BA",
            "level4_description": "Benzodiazepine derivatives",
            "level5": "N05BA14",
            "who_name": "pinazepam"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05B",
            "level3_description": "ANXIOLYTICS",
            "level4": "N05BA",
            "level4_description": "Benzodiazepine derivatives",
            "level5": "N05BA15",
            "who_name": "camazepam"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05B",
            "level3_description": "ANXIOLYTICS",
            "level4": "N05BA",
            "level4_description": "Benzodiazepine derivatives",
            "level5": "N05BA16",
            "who_name": "nordazepam"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05B",
            "level3_description": "ANXIOLYTICS",
            "level4": "N05BA",
            "level4_description": "Benzodiazepine derivatives",
            "level5": "N05BA17",
            "who_name": "fludiazepam"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05B",
            "level3_description": "ANXIOLYTICS",
            "level4": "N05BA",
            "level4_description": "Benzodiazepine derivatives",
            "level5": "N05BA18",
            "who_name": "ethyl loflazepate"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05B",
            "level3_description": "ANXIOLYTICS",
            "level4": "N05BA",
            "level4_description": "Benzodiazepine derivatives",
            "level5": "N05BA19",
            "who_name": "etizolam"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05B",
            "level3_description": "ANXIOLYTICS",
            "level4": "N05BA",
            "level4_description": "Benzodiazepine derivatives",
            "level5": "N05BA21",
            "who_name": "clotiazepam"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05B",
            "level3_description": "ANXIOLYTICS",
            "level4": "N05BA",
            "level4_description": "Benzodiazepine derivatives",
            "level5": "N05BA22",
            "who_name": "cloxazolam"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05B",
            "level3_description": "ANXIOLYTICS",
            "level4": "N05BA",
            "level4_description": "Benzodiazepine derivatives",
            "level5": "N05BA23",
            "who_name": "tofisopam"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05B",
            "level3_description": "ANXIOLYTICS",
            "level4": "N05BA",
            "level4_description": "Benzodiazepine derivatives",
            "level5": "N05BA24",
            "who_name": "bentazepam"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05B",
            "level3_description": "ANXIOLYTICS",
            "level4": "N05BA",
            "level4_description": "Benzodiazepine derivatives",
            "level5": "N05BA25",
            "who_name": "mexazolam"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05B",
            "level3_description": "ANXIOLYTICS",
            "level4": "N05BA",
            "level4_description": "Benzodiazepine derivatives",
            "level5": "N05BA56",
            "who_name": "lorazepam, combinations"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05B",
            "level3_description": "ANXIOLYTICS",
            "level4": "N05BB",
            "level4_description": "Diphenylmethane derivatives",
            "level5": "N05BB01",
            "who_name": "hydroxyzine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05B",
            "level3_description": "ANXIOLYTICS",
            "level4": "N05BB",
            "level4_description": "Diphenylmethane derivatives",
            "level5": "N05BB02",
            "who_name": "captodiame"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05B",
            "level3_description": "ANXIOLYTICS",
            "level4": "N05BB",
            "level4_description": "Diphenylmethane derivatives",
            "level5": "N05BB51",
            "who_name": "hydroxyzine, combinations"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05B",
            "level3_description": "ANXIOLYTICS",
            "level4": "N05BC",
            "level4_description": "Carbamates",
            "level5": "N05BC01",
            "who_name": "meprobamate"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05B",
            "level3_description": "ANXIOLYTICS",
            "level4": "N05BC",
            "level4_description": "Carbamates",
            "level5": "N05BC03",
            "who_name": "emylcamate"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05B",
            "level3_description": "ANXIOLYTICS",
            "level4": "N05BC",
            "level4_description": "Carbamates",
            "level5": "N05BC04",
            "who_name": "mebutamate"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05B",
            "level3_description": "ANXIOLYTICS",
            "level4": "N05BC",
            "level4_description": "Carbamates",
            "level5": "N05BC51",
            "who_name": "meprobamate, combinations"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05B",
            "level3_description": "ANXIOLYTICS",
            "level4": "N05BD",
            "level4_description": "Dibenzo-bicyclo-octadiene derivatives",
            "level5": "N05BD01",
            "who_name": "benzoctamine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05B",
            "level3_description": "ANXIOLYTICS",
            "level4": "N05BE",
            "level4_description": "Azaspirodecanedione derivatives",
            "level5": "N05BE01",
            "who_name": "buspirone"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05B",
            "level3_description": "ANXIOLYTICS",
            "level4": "N05BX",
            "level4_description": "Other anxiolytics",
            "level5": "N05BX01",
            "who_name": "mephenoxalone"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05B",
            "level3_description": "ANXIOLYTICS",
            "level4": "N05BX",
            "level4_description": "Other anxiolytics",
            "level5": "N05BX02",
            "who_name": "gedocarnil"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05B",
            "level3_description": "ANXIOLYTICS",
            "level4": "N05BX",
            "level4_description": "Other anxiolytics",
            "level5": "N05BX03",
            "who_name": "etifoxine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05B",
            "level3_description": "ANXIOLYTICS",
            "level4": "N05BX",
            "level4_description": "Other anxiolytics",
            "level5": "N05BX04",
            "who_name": "fabomotizole"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05B",
            "level3_description": "ANXIOLYTICS",
            "level4": "N05BX",
            "level4_description": "Other anxiolytics",
            "level5": "N05BX05",
            "who_name": "Lavandulae aetheroleum"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CA",
            "level4_description": "Barbiturates, plain",
            "level5": "N05CA01",
            "who_name": "pentobarbital"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CA",
            "level4_description": "Barbiturates, plain",
            "level5": "N05CA02",
            "who_name": "amobarbital"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CA",
            "level4_description": "Barbiturates, plain",
            "level5": "N05CA03",
            "who_name": "butobarbital"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CA",
            "level4_description": "Barbiturates, plain",
            "level5": "N05CA04",
            "who_name": "barbital"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CA",
            "level4_description": "Barbiturates, plain",
            "level5": "N05CA05",
            "who_name": "aprobarbital"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CA",
            "level4_description": "Barbiturates, plain",
            "level5": "N05CA06",
            "who_name": "secobarbital"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CA",
            "level4_description": "Barbiturates, plain",
            "level5": "N05CA07",
            "who_name": "talbutal"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CA",
            "level4_description": "Barbiturates, plain",
            "level5": "N05CA08",
            "who_name": "vinylbital"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CA",
            "level4_description": "Barbiturates, plain",
            "level5": "N05CA09",
            "who_name": "vinbarbital"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CA",
            "level4_description": "Barbiturates, plain",
            "level5": "N05CA10",
            "who_name": "cyclobarbital"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CA",
            "level4_description": "Barbiturates, plain",
            "level5": "N05CA11",
            "who_name": "heptabarbital"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CA",
            "level4_description": "Barbiturates, plain",
            "level5": "N05CA12",
            "who_name": "reposal"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CA",
            "level4_description": "Barbiturates, plain",
            "level5": "N05CA15",
            "who_name": "methohexital"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CA",
            "level4_description": "Barbiturates, plain",
            "level5": "N05CA16",
            "who_name": "hexobarbital"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CA",
            "level4_description": "Barbiturates, plain",
            "level5": "N05CA19",
            "who_name": "thiopental"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CA",
            "level4_description": "Barbiturates, plain",
            "level5": "N05CA20",
            "who_name": "etallobarbital"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CA",
            "level4_description": "Barbiturates, plain",
            "level5": "N05CA21",
            "who_name": "allobarbital"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CA",
            "level4_description": "Barbiturates, plain",
            "level5": "N05CA22",
            "who_name": "proxibarbal"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CB",
            "level4_description": "Barbiturates, combinations",
            "level5": "N05CB01",
            "who_name": "combinations of barbiturates"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CB",
            "level4_description": "Barbiturates, combinations",
            "level5": "N05CB02",
            "who_name": "barbiturates in combination with other drugs"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CC",
            "level4_description": "Aldehydes and derivatives",
            "level5": "N05CC01",
            "who_name": "chloral hydrate"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CC",
            "level4_description": "Aldehydes and derivatives",
            "level5": "N05CC02",
            "who_name": "chloralodol"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CC",
            "level4_description": "Aldehydes and derivatives",
            "level5": "N05CC03",
            "who_name": "acetylglycinamide chloral hydrate"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CC",
            "level4_description": "Aldehydes and derivatives",
            "level5": "N05CC04",
            "who_name": "dichloralphenazone"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CC",
            "level4_description": "Aldehydes and derivatives",
            "level5": "N05CC05",
            "who_name": "paraldehyde"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CD",
            "level4_description": "Benzodiazepine derivatives",
            "level5": "N05CD01",
            "who_name": "flurazepam"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CD",
            "level4_description": "Benzodiazepine derivatives",
            "level5": "N05CD02",
            "who_name": "nitrazepam"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CD",
            "level4_description": "Benzodiazepine derivatives",
            "level5": "N05CD03",
            "who_name": "flunitrazepam"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CD",
            "level4_description": "Benzodiazepine derivatives",
            "level5": "N05CD04",
            "who_name": "estazolam"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CD",
            "level4_description": "Benzodiazepine derivatives",
            "level5": "N05CD05",
            "who_name": "triazolam"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CD",
            "level4_description": "Benzodiazepine derivatives",
            "level5": "N05CD06",
            "who_name": "lormetazepam"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CD",
            "level4_description": "Benzodiazepine derivatives",
            "level5": "N05CD07",
            "who_name": "temazepam"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CD",
            "level4_description": "Benzodiazepine derivatives",
            "level5": "N05CD08",
            "who_name": "midazolam"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CD",
            "level4_description": "Benzodiazepine derivatives",
            "level5": "N05CD09",
            "who_name": "brotizolam"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CD",
            "level4_description": "Benzodiazepine derivatives",
            "level5": "N05CD10",
            "who_name": "quazepam"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CD",
            "level4_description": "Benzodiazepine derivatives",
            "level5": "N05CD11",
            "who_name": "loprazolam"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CD",
            "level4_description": "Benzodiazepine derivatives",
            "level5": "N05CD12",
            "who_name": "doxefazepam"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CD",
            "level4_description": "Benzodiazepine derivatives",
            "level5": "N05CD13",
            "who_name": "cinolazepam"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CD",
            "level4_description": "Benzodiazepine derivatives",
            "level5": "N05CD14",
            "who_name": "remimazolam"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CD",
            "level4_description": "Benzodiazepine derivatives",
            "level5": "N05CD15",
            "who_name": "nimetazepam"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CE",
            "level4_description": "Piperidinedione derivatives",
            "level5": "N05CE01",
            "who_name": "glutethimide"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CE",
            "level4_description": "Piperidinedione derivatives",
            "level5": "N05CE02",
            "who_name": "methyprylon"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CE",
            "level4_description": "Piperidinedione derivatives",
            "level5": "N05CE03",
            "who_name": "pyrithyldione"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CF",
            "level4_description": "Benzodiazepine related drugs",
            "level5": "N05CF01",
            "who_name": "zopiclone"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CF",
            "level4_description": "Benzodiazepine related drugs",
            "level5": "N05CF02",
            "who_name": "zolpidem"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CF",
            "level4_description": "Benzodiazepine related drugs",
            "level5": "N05CF03",
            "who_name": "zaleplon"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CF",
            "level4_description": "Benzodiazepine related drugs",
            "level5": "N05CF04",
            "who_name": "eszopiclone"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CH",
            "level4_description": "Melatonin receptor agonists",
            "level5": "N05CH01",
            "who_name": "melatonin"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CH",
            "level4_description": "Melatonin receptor agonists",
            "level5": "N05CH02",
            "who_name": "ramelteon"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CH",
            "level4_description": "Melatonin receptor agonists",
            "level5": "N05CH03",
            "who_name": "tasimelteon"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CM",
            "level4_description": "Other hypnotics and sedatives",
            "level5": "N05CM01",
            "who_name": "methaqualone"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CM",
            "level4_description": "Other hypnotics and sedatives",
            "level5": "N05CM02",
            "who_name": "clomethiazole"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CM",
            "level4_description": "Other hypnotics and sedatives",
            "level5": "N05CM03",
            "who_name": "bromisoval"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CM",
            "level4_description": "Other hypnotics and sedatives",
            "level5": "N05CM04",
            "who_name": "carbromal"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CM",
            "level4_description": "Other hypnotics and sedatives",
            "level5": "N05CM05",
            "who_name": "scopolamine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CM",
            "level4_description": "Other hypnotics and sedatives",
            "level5": "N05CM06",
            "who_name": "propiomazine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CM",
            "level4_description": "Other hypnotics and sedatives",
            "level5": "N05CM07",
            "who_name": "triclofos"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CM",
            "level4_description": "Other hypnotics and sedatives",
            "level5": "N05CM08",
            "who_name": "ethchlorvynol"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CM",
            "level4_description": "Other hypnotics and sedatives",
            "level5": "N05CM09",
            "who_name": "Valerianae radix"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CM",
            "level4_description": "Other hypnotics and sedatives",
            "level5": "N05CM10",
            "who_name": "hexapropymate"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CM",
            "level4_description": "Other hypnotics and sedatives",
            "level5": "N05CM11",
            "who_name": "bromides"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CM",
            "level4_description": "Other hypnotics and sedatives",
            "level5": "N05CM12",
            "who_name": "apronal"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CM",
            "level4_description": "Other hypnotics and sedatives",
            "level5": "N05CM13",
            "who_name": "valnoctamide"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CM",
            "level4_description": "Other hypnotics and sedatives",
            "level5": "N05CM15",
            "who_name": "methylpentynol"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CM",
            "level4_description": "Other hypnotics and sedatives",
            "level5": "N05CM16",
            "who_name": "niaprazine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CM",
            "level4_description": "Other hypnotics and sedatives",
            "level5": "N05CM18",
            "who_name": "dexmedetomidine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CM",
            "level4_description": "Other hypnotics and sedatives",
            "level5": "N05CM19",
            "who_name": "suvorexant"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CM",
            "level4_description": "Other hypnotics and sedatives",
            "level5": "N05CM21",
            "who_name": "lemborexant"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CX",
            "level4_description": "Hypnotics and sedatives in combination, excl. barbiturates",
            "level5": "N05CX01",
            "who_name": "meprobamate, combinations"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CX",
            "level4_description": "Hypnotics and sedatives in combination, excl. barbiturates",
            "level5": "N05CX02",
            "who_name": "methaqualone, combinations"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CX",
            "level4_description": "Hypnotics and sedatives in combination, excl. barbiturates",
            "level5": "N05CX03",
            "who_name": "methylpentynol, combinations"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CX",
            "level4_description": "Hypnotics and sedatives in combination, excl. barbiturates",
            "level5": "N05CX04",
            "who_name": "clomethiazole, combinations"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CX",
            "level4_description": "Hypnotics and sedatives in combination, excl. barbiturates",
            "level5": "N05CX05",
            "who_name": "emepronium, combinations"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N05",
            "level2_description": "PSYCHOLEPTICS",
            "level3": "N05C",
            "level3_description": "HYPNOTICS AND SEDATIVES",
            "level4": "N05CX",
            "level4_description": "Hypnotics and sedatives in combination, excl. barbiturates",
            "level5": "N05CX06",
            "who_name": "dipiperonylaminoethanol, combinations"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N06",
            "level2_description": "PSYCHOANALEPTICS",
            "level3": "N06A",
            "level3_description": "ANTIDEPRESSANTS",
            "level4": "N06AA",
            "level4_description": "Non-selective monoamine reuptake inhibitors",
            "level5": "N06AA01",
            "who_name": "desipramine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N06",
            "level2_description": "PSYCHOANALEPTICS",
            "level3": "N06A",
            "level3_description": "ANTIDEPRESSANTS",
            "level4": "N06AA",
            "level4_description": "Non-selective monoamine reuptake inhibitors",
            "level5": "N06AA02",
            "who_name": "imipramine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N06",
            "level2_description": "PSYCHOANALEPTICS",
            "level3": "N06A",
            "level3_description": "ANTIDEPRESSANTS",
            "level4": "N06AA",
            "level4_description": "Non-selective monoamine reuptake inhibitors",
            "level5": "N06AA03",
            "who_name": "imipramine oxide"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N06",
            "level2_description": "PSYCHOANALEPTICS",
            "level3": "N06A",
            "level3_description": "ANTIDEPRESSANTS",
            "level4": "N06AA",
            "level4_description": "Non-selective monoamine reuptake inhibitors",
            "level5": "N06AA04",
            "who_name": "clomipramine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N06",
            "level2_description": "PSYCHOANALEPTICS",
            "level3": "N06A",
            "level3_description": "ANTIDEPRESSANTS",
            "level4": "N06AA",
            "level4_description": "Non-selective monoamine reuptake inhibitors",
            "level5": "N06AA05",
            "who_name": "opipramol"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N06",
            "level2_description": "PSYCHOANALEPTICS",
            "level3": "N06A",
            "level3_description": "ANTIDEPRESSANTS",
            "level4": "N06AA",
            "level4_description": "Non-selective monoamine reuptake inhibitors",
            "level5": "N06AA06",
            "who_name": "trimipramine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N06",
            "level2_description": "PSYCHOANALEPTICS",
            "level3": "N06A",
            "level3_description": "ANTIDEPRESSANTS",
            "level4": "N06AA",
            "level4_description": "Non-selective monoamine reuptake inhibitors",
            "level5": "N06AA07",
            "who_name": "lofepramine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N06",
            "level2_description": "PSYCHOANALEPTICS",
            "level3": "N06A",
            "level3_description": "ANTIDEPRESSANTS",
            "level4": "N06AA",
            "level4_description": "Non-selective monoamine reuptake inhibitors",
            "level5": "N06AA08",
            "who_name": "dibenzepin"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N06",
            "level2_description": "PSYCHOANALEPTICS",
            "level3": "N06A",
            "level3_description": "ANTIDEPRESSANTS",
            "level4": "N06AA",
            "level4_description": "Non-selective monoamine reuptake inhibitors",
            "level5": "N06AA09",
            "who_name": "amitriptyline"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N06",
            "level2_description": "PSYCHOANALEPTICS",
            "level3": "N06A",
            "level3_description": "ANTIDEPRESSANTS",
            "level4": "N06AA",
            "level4_description": "Non-selective monoamine reuptake inhibitors",
            "level5": "N06AA10",
            "who_name": "nortriptyline"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N06",
            "level2_description": "PSYCHOANALEPTICS",
            "level3": "N06A",
            "level3_description": "ANTIDEPRESSANTS",
            "level4": "N06AA",
            "level4_description": "Non-selective monoamine reuptake inhibitors",
            "level5": "N06AA11",
            "who_name": "protriptyline"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N06",
            "level2_description": "PSYCHOANALEPTICS",
            "level3": "N06A",
            "level3_description": "ANTIDEPRESSANTS",
            "level4": "N06AA",
            "level4_description": "Non-selective monoamine reuptake inhibitors",
            "level5": "N06AA12",
            "who_name": "doxepin"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N06",
            "level2_description": "PSYCHOANALEPTICS",
            "level3": "N06A",
            "level3_description": "ANTIDEPRESSANTS",
            "level4": "N06AA",
            "level4_description": "Non-selective monoamine reuptake inhibitors",
            "level5": "N06AA13",
            "who_name": "iprindole"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N06",
            "level2_description": "PSYCHOANALEPTICS",
            "level3": "N06A",
            "level3_description": "ANTIDEPRESSANTS",
            "level4": "N06AA",
            "level4_description": "Non-selective monoamine reuptake inhibitors",
            "level5": "N06AA14",
            "who_name": "melitracen"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N06",
            "level2_description": "PSYCHOANALEPTICS",
            "level3": "N06A",
            "level3_description": "ANTIDEPRESSANTS",
            "level4": "N06AA",
            "level4_description": "Non-selective monoamine reuptake inhibitors",
            "level5": "N06AA15",
            "who_name": "butriptyline"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N06",
            "level2_description": "PSYCHOANALEPTICS",
            "level3": "N06A",
            "level3_description": "ANTIDEPRESSANTS",
            "level4": "N06AA",
            "level4_description": "Non-selective monoamine reuptake inhibitors",
            "level5": "N06AA16",
            "who_name": "dosulepin"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N06",
            "level2_description": "PSYCHOANALEPTICS",
            "level3": "N06A",
            "level3_description": "ANTIDEPRESSANTS",
            "level4": "N06AA",
            "level4_description": "Non-selective monoamine reuptake inhibitors",
            "level5": "N06AA17",
            "who_name": "amoxapine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N06",
            "level2_description": "PSYCHOANALEPTICS",
            "level3": "N06A",
            "level3_description": "ANTIDEPRESSANTS",
            "level4": "N06AA",
            "level4_description": "Non-selective monoamine reuptake inhibitors",
            "level5": "N06AA18",
            "who_name": "dimetacrine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N06",
            "level2_description": "PSYCHOANALEPTICS",
            "level3": "N06A",
            "level3_description": "ANTIDEPRESSANTS",
            "level4": "N06AA",
            "level4_description": "Non-selective monoamine reuptake inhibitors",
            "level5": "N06AA19",
            "who_name": "amineptine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N06",
            "level2_description": "PSYCHOANALEPTICS",
            "level3": "N06A",
            "level3_description": "ANTIDEPRESSANTS",
            "level4": "N06AA",
            "level4_description": "Non-selective monoamine reuptake inhibitors",
            "level5": "N06AA21",
            "who_name": "maprotiline"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N06",
            "level2_description": "PSYCHOANALEPTICS",
            "level3": "N06A",
            "level3_description": "ANTIDEPRESSANTS",
            "level4": "N06AA",
            "level4_description": "Non-selective monoamine reuptake inhibitors",
            "level5": "N06AA23",
            "who_name": "quinupramine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N06",
            "level2_description": "PSYCHOANALEPTICS",
            "level3": "N06A",
            "level3_description": "ANTIDEPRESSANTS",
            "level4": "N06AB",
            "level4_description": "Selective serotonin reuptake inhibitors",
            "level5": "N06AB02",
            "who_name": "zimeldine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N06",
            "level2_description": "PSYCHOANALEPTICS",
            "level3": "N06A",
            "level3_description": "ANTIDEPRESSANTS",
            "level4": "N06AB",
            "level4_description": "Selective serotonin reuptake inhibitors",
            "level5": "N06AB03",
            "who_name": "fluoxetine"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N06",
            "level2_description": "PSYCHOANALEPTICS",
            "level3": "N06A",
            "level3_description": "ANTIDEPRESSANTS",
            "level4": "N06AB",
            "level4_description": "Selective serotonin reuptake inhibitors",
            "level5": "N06AB04",
            "who_name": "citalopram"
        },
        {
            "level1": "N",
            "level1_description": "NERVOUS SYSTEM",
            "level2": "N06",
            "level2_description": "PSYCHOANALEPTICS",
            "level3": "N06A",
            "level3_description": "ANTIDEPRESSANTS",
            "level4": "N06AB",
            "level4_description": "Selective serotonin reuptake inhibitors",
            "level5": "N06AB05",
            "who_name": "paroxetine"
        }
    ],
    "page_meta": {
        "limit": 1000,
        "next": "/chembl/api/data/atc_class.json?limit=1000&offset=4000",
        "offset": 3000,
        "previous": "/chembl/api/data/atc_class.json?limit=1000&offset=2000",
        "total_count": 5265
    }
}
